Document:

EX-10.8

 Exhibit 10.8 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT, dated as of April 25, 2014 (this “Agreement”), is by and between Milacron Holdings Inc., a
Delaware corporation (together with any other current or future holding company set up to hold, directly or indirectly, the stock or assets of Milacron Holdings Inc., the “Company”), and John Gallagher (the
“Executive”). 
 WHEREAS, effective as of the Effective Date (as defined below), the Company desires to employ the
Executive and enter into an agreement embodying the terms of such employment, and the Executive desires to accept such employment and enter into such an agreement; and 

WHEREAS, the Company has determined that it is in the best interests of the Company and its shareholders to employ the Executive in the
capacity set forth in this Agreement, and the Executive is willing to serve in such capacity as an employee of the Company, subject to the terms and conditions of this Agreement. 

NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS: 

1. Employment and Duties. 

(a) General. Starting and effective as of May 1, 2014 (the “Effective Date”), the Executive shall serve as the
Chief Operating Officer of Melt Delivery & Control Systems, Fluid Technologies, and Financial & Shared Services, and shall report directly to the Chief Executive Officer of the Company (the “CEO”). The Executive
shall have such duties and responsibilities, commensurate with the Executive’s position, as may be assigned to the Executive from time to time by the CEO. The Executive’s principal place of employment shall be the headquarters of the
Company, currently located in Cincinnati, Ohio; provided, however, that the Executive understands and agrees that he will be required to travel from time to time for business reasons. 

(b) Exclusive Services. For so long as the Executive is employed by the Company, the Executive shall devote his full-time working time
to his duties hereunder, shall faithfully serve the Company, shall in all material respects conform to and comply with the lawful directions and instructions given to him by the CEO and shall use his reasonable best efforts to promote and serve the
interests of the Company. Further, the Executive shall not, directly or indirectly, render services to any other person or organization without the consent of the CEO or otherwise engage in activities that would interfere in any material respect
with his faithful performance of his duties hereunder. Notwithstanding the foregoing, the Executive may (i) continue to serve on the board of Kraton Polymers; and (ii) serve on not-for-profit corporate, civic or charitable boards or engage
in charitable activities without remuneration therefor, provided that such activity does not contravene the first sentence of this Section 1(b). 

2. Term. The initial term of the Executive’s employment under this Agreement shall commence on the Effective Date and shall expire
on the fifth anniversary of the Effective Date (the “Initial Term”); provided, however, that the Initial Term of the Executive’s employment shall be automatically extended without further action of either party
for additional one-year periods, unless written notice of either party’s intention not to extend the term has been given to the other party at least six months prior to the expiration of the then-effective term. The Initial Term, together with
any extensions, is referred to herein as the “Term.” 

 3. Definitions. 

(a) Termination for “Cause” means termination of the Executive’s employment because of: 

(i) any act or omission that constitutes a material breach by the Executive of any of his obligations under this Agreement or
any written policy of the Company, including, without limitation, the willful and continued failure or refusal of the Executive to substantially perform the duties reasonably required of him as an employee of the Company; 

(ii) the Executive’s conviction of, or plea of nolo contendere to, (A) any felony or (B) another crime involving
material acts of dishonesty or moral turpitude that relates to the property of the Company or which is or could reasonably be expected to be materially injurious to the financial condition or business reputation of the Company or any of its
subsidiaries or affiliates; 
 (iii) the Executive’s engaging in any willful misconduct which is or could reasonably be
expected to be materially injurious to the financial condition or business reputation of the Company or any of its subsidiaries or affiliates; or 

(iv) the Executive’s engaging in any intentional act of dishonesty, violence or threat of violence (including any
violation of federal securities laws) which is or could reasonably be expected to be materially injurious to the financial condition or business reputation of the Company or any of its subsidiaries or affiliates. 

In the event of the existence of grounds that would constitute Cause as contemplated in subsections (i) or (iii) above, such grounds shall
constitute Cause only if the Company provides written notice to the Executive of the grounds and the facts which constitute Cause within 90 days following the Board’s initial knowledge of the grounds and the Executive thereafter fails to cure
such grounds within 30 business days following his receipt of such notice (or, in the event that such grounds cannot be corrected within such 30 day period, the Executive has not taken all reasonable steps within such 30 day period to correct such
grounds as promptly as practicable thereafter). 
 (b) Resignation for “Good Reason” means termination of employment by the
Executive because of the occurrence of any of the following events: 
 (i) there is a material reduction in the
Executive’s Base Salary, unless agreed to in writing by the Executive; 
 (ii) there is a material reduction in the
Executive’s authority, duties, or responsibilities; 

  
 2 

 (iii) the Executive is required to relocate to a different principal place of
business that is located more than 100 miles away from the Company’s headquarters in Cincinnati, Ohio, other than required travel as contemplated by Section 1(a) hereof; or 

(iv) the Company’s delivery to the Executive of a notice of non-renewal of the Term, as provided in Section 2. 

In the event of existence of grounds that would constitute Good Reason as contemplated in subsections (i), (ii) or (iii) above, such grounds shall
constitute Good Reason only if the Executive provides written notice to the Company of the facts which constitute the grounds within 90 days following the Executive’s initial knowledge of the grounds and the Company thereafter fails to cure
such grounds within 30 business days following its receipt of such notice (or, in the event that such grounds cannot be corrected within such 30-day period, the Company has not taken all reasonable steps within such 30-day period to correct such
grounds as promptly as practicable thereafter). 
 4. Compensation and Other Benefits. Subject to the provisions of this Agreement,
the Company shall pay and provide the following compensation and other benefits to the Executive during the Term as compensation for services rendered hereunder: 

(a) Base Salary. The Company shall pay to the Executive an annual salary (the “Base Salary”) at the rate of $600,000,
payable in substantially equal installments at such intervals as may be determined by the Company in accordance with its ordinary payroll practices, as established from time to time. The Base Salary shall be reviewed by the CEO not less often than
annually. The Base Salary shall not be decreased by the Company except with the prior written consent of the Executive. 
 (b) Annual
Bonus. For each fiscal year during the Term, the Executive shall be eligible to receive an incentive bonus expressed as a percentage of his Base Salary (the “Annual Bonus”). The Executive’s target Annual Bonus will be equal
to 75% of Base Salary. The Annual Bonus will be paid in a lump sum within thirty (30) days after the Company’s receipt of the final audited financial statements of the Company for the fiscal year to which such Annual Bonus relates, but in
no event later than December 31 of the calendar year following the calendar year to which such bonus relates. The actual Annual Bonus shall be determined in accordance with the Milacron Bonus Plan established by the Company’s Board of
Directors or a committee thereof (the “Board”) and based upon performance goals established by the CEO and/or the Board which performance goals will generally be communicated to the Executive no more than 90 days before the
beginning of the fiscal year in which the performance goals apply. Such performance goals shall be based on synergies, EBITDA, debt repayment, maintenance of financial ratios, cash flow or any other such measures as deemed appropriate by the CEO
and/or Board. Notwithstanding the foregoing, the Executive’s Annual Bonus opportunity for the 2014 fiscal year shall be pro-rated based on the number of days that the Executive is employed during such year. 

  
 3 

 (c) Stock Option Award. Subject to the approval of the Board, the Executive shall be
issued an option to purchase 5,500 shares of common stock of the Company (the “Option”) in accordance with the terms of the Nonqualified Stock Option Agreement attached as Exhibit B hereto (the “Option Agreement”).
Further, notwithstanding anything to the contrary in the Option Agreement, if the Executive’s employment is terminated following the Executive’s successful completion of the Executive’s role, as reasonably determined by the Board in
its sole discretion, then the following terms shall apply to the Option: 
 (i) The portion of the Time Option (as defined in
the Option Agreement) that is scheduled to vest on the Time Vesting Date (as defined in the Option Agreement) immediately following the date of the Executive’s termination of employment shall remain outstanding and eligible to vest on such Time
Vesting Date, subject to the Executive’s continued compliance with the non-competition, non-solicitation and other restrictive covenants set forth herein and any other restrictive covenants with the Company or its affiliates to which the
Executive is bound (the “Restrictive Covenants”). For the avoidance of doubt, any other portion of the Time Option that is unvested on the date of the Executive’s termination of employment shall terminate and be forfeited upon
termination of employment. 
 (ii) The Performance Option (as defined in the Option Agreement) shall not be forfeited upon
the termination date and shall instead remain outstanding and eligible to vest in accordance with Section 2.b.ii. and other terms and conditions of the Option Agreement, subject to the Executive’s continued compliance with the Restrictive
Covenants through the applicable vesting date. 
 (iii) The portion of the Option that is vested as of the date of the
Executive’s termination of Employment and any portion of the Option that vests thereafter in accordance with this Section 4(c) shall remain outstanding and exercisable until the Expiration Date (as defined in the Option Agreement). 

For the avoidance of doubt, the benefits set forth in this Section 4(c) shall be triggered only upon a reasonable determination by the Board
in its sole discretion that the Executive has successfully completed his role, regardless of whether the Executive’s employment is terminated without Cause or otherwise. 

(d) Savings and Retirement Plans. The Executive shall be eligible to participate in all savings and retirement plans applicable
generally to other executives of the Company, in accordance with the terms of the plans, as may be amended from time to time. 
 (e)
Welfare Benefit Plans. The Executive and his eligible dependents shall be eligible to participate in and shall receive all benefits under the Company’s welfare benefit plans and programs applicable generally to other executives of the
Company, in accordance with the terms of the plans, as may be amended from time to time. 
 (f) Expenses. Upon presentation of written
documentation thereof, in accordance with the applicable expense reimbursement policies and procedures of the Company as in effect from time to time, the Company shall reimburse the Executive for reasonable business-related expenses incurred by the
Executive in the fulfillment of his duties. Payments with respect to reimbursements of expenses shall be made promptly and in accordance with the applicable expense reimbursement policies and procedures of the Company, but in any event, on 

  
 4 

 
or before the last day of the calendar year following the calendar year in which the relevant expense is incurred. The amount of expenses eligible for reimbursement during a calendar year may not
affect the expenses eligible for reimbursement in any other calendar year. 
 (g) Relocation. Unless the Company and the Executive
mutually agree to a different arrangement, the Company shall pay or reimburse the Executive in accordance with Company policy for the reasonable expenses he incurs in connection with his relocation to the Cincinnati, Ohio area, which relocation
shall occur within a reasonable an mutually satisfactory period of time following the Effective Date, subject to the Executive providing the Company with receipts or other written documentation of such expenses. 

(h) Company Car. The Executive shall be provided with a company car or a car allowance in accordance with Company policy. 

(i) Vacation. The Executive shall be entitled to four weeks of paid vacation each year during the Term, subject to the Company’s
vacation policy in effect from time to time. 
 (j) Indemnification. To the fullest extent permitted by the indemnification provisions
of the laws of the State of Delaware in effect from time to time, and subject to the conditions thereof, the Company shall (A) indemnify the Executive, as an officer of the Company, against all liabilities and reasonable expenses that the
Executive may incur in any threatened, pending, or completed action, suit or proceeding, whether civil, criminal or administrative, or investigative and whether formal or informal, because the Executive is or was an officer of the Company (or is or
was serving, at the request of the Company, as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other entity), and against which the Executive may be indemnified by the Company, and (B) upon submission
of appropriate documentation, pay for or reimburse in advance the reasonable expenses incurred or to be incurred by the Executive in the defense of any proceeding to which the Executive is a party because the Executive is or was an officer of the
Company (or is or was serving, at the request of the Company, as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other entity). The rights of the Executive hereunder and under the Articles of Incorporation
and Bylaws of the Company and under the laws of the State of Delaware shall survive the termination of the employment of the Executive by the Company. Unless specifically so provided therein, no amendment, alteration or repeal of this Agreement or
of any provision hereof shall limit or restrict any right of the Executive under this Agreement in respect of any action taken or omitted by the Executive prior to such amendment, alteration or repeal. To the extent that a change in the laws of the
State of Delaware, whether by statute or judicial decision, permits greater indemnification than would be afforded currently under the laws of the State of Delaware, it is the intent of the parties hereto that the Executive shall enjoy by this
Agreement the greater benefits afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy (including under the Articles of Incorporation or Bylaws of the Company), and every other right or
remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise (including under the Articles of Incorporation or Bylaws of the Company). 

  
 5 

 (k) Board Fee. The Executive will not receive a fee or any other cash compensation as a
result of his service on the Board during the Term, however, the stock options previously granted to the Executive in consideration of his service to the Board will continue to vest in accordance with the terms of such stock options. In the event
that the Executive’s service with the Company is terminated under this Agreement and he remains on the Board, he shall again be eligible for such fees and other compensation as are applicable to Board members at that time. 

5. Termination of Employment. 

(a) Termination for Cause; Resignation Without Good Reason. If, prior to the expiration of the Term, the Executive incurs a
“Separation from Service” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), by reason of the Company’s termination of the Executive’s employment for Cause, or
if the Executive resigns from his employment hereunder other than for Good Reason, the Executive shall be entitled only to payment of any unpaid Base Salary through and including the date of termination or resignation, any Annual Bonus earned, but
unpaid, for the year immediately preceding the year in which the termination date occurs (which unpaid Annual Bonus amount shall be paid in accordance with Section 4(b)), and any other amounts or benefits required to be paid or provided by law
or under any plan, program, policy or practice of the Company (such other amounts or benefits being referred to collectively as the “Other Accrued Compensation and Benefits”). Except as set forth in this subsection (a), the
Executive shall have no further right to receive any other compensation or benefits after such termination or resignation of employment. 

(b) Termination without Cause; Resignation for Good Reason. 

(i) If the Executive incurs a “Separation from Service” within the meaning of Section 409A of the Code, by
reason of the Company’s termination of the Executive’s employment without Cause, or if the Executive resigns from his employment hereunder for Good Reason, the Executive shall be entitled to the following: 

(A) an amount equal to 18 months’ Base Salary, payable in equal installments over a period of 18 months; 

(B) an amount equal to the full premium amount (determined as of the date of termination on a pre-tax basis) for continued
coverage under the Company’s health plan pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), for the Executive, and, to the extent that the Executive is providing coverage for his
spouse or eligible dependents as of the termination date, for such individuals; provided, however, that the Company’s obligation to pay such premiums shall cease immediately upon the earlier of the expiration of the statutory
COBRA period and the date the Executive becomes eligible for coverage under any other group health plan (as an employee or otherwise) as defined for purposes of COBRA or Medicare; 

  
 6 

 (C) to the extent provided in the Milacron Bonus Plan for such year, a pro rata
Annual Bonus for the year in which the date of termination occurs, which Annual Bonus shall be based on actual performance and paid at the same time that bonuses are paid to other executives generally during the year following the year in which the
date of termination occurs; and 
 (D) any Other Accrued Compensation and Benefits. 

(ii) The payments and benefits provided under Sections 5(b)(i)(A) and 5(b)(i)(B) shall commence on the first payroll date
following the 60th day after the Executive’s termination of employment. The Company shall not be required to make the payments and provide the benefits provided for under Sections 5(b)(i)(A) through 5(b)(i)(C) unless the Executive executes and
delivers to the Company, within 60 days following the Executive’s termination of employment, a release substantially in the form attached hereto as Exhibit A, and the release has become effective and irrevocable in its entirety in such 60-day
period. The Executive’s failure or refusal to sign the release (or the Executive’s revocation of such release in accordance with applicable laws) will result in the forfeiture of the payments and benefits under Sections 5(b)(i)(A) through
5(b)(i)(C). 
 (iii) If, following a termination of employment without Cause or a resignation for Good Reason, the Executive
breaches the provisions of Sections 6 through 13 hereof or breaches any provision set forth in the executed copy of the General Release of Claims, the Executive shall not be eligible, as of the date of such breach, for the payments and benefits
described in Section 5(b)(A)-(C), and any and all obligations and agreements of the Company with respect to such payments shall thereupon cease. 

(c) Termination Due to Death or Disability. The Executive’s employment with the Company shall terminate automatically on the
Executive’s death. In the event of the Executive’s Disability (as defined herein), the Company shall be entitled to terminate his employment. In the event of the Executive’s death or if the Executive incurs a “Separation from
Service” within the meaning of Section 409A of the Code by reason of the Executive’s Disability, the Company shall pay to the Executive (or his estate, as applicable), the Executive’s Base Salary through and including the date of
termination and any Other Accrued Compensation and Benefits. For purposes of this Agreement, “Disability” means a physical or mental disability or infirmity of the Executive that prevents the normal performance of substantially all
his duties for a period in excess of 90 consecutive days or for more than 180 days in any consecutive 12-month period. Evidence of such physical or mental disability or infirmity shall be certified by a physician licensed to practice in the state of
residence of the Executive, which physician is mutually agreeable to the CEO and the Executive. If there is no agreement on the selection of the physician, then the CEO shall select one physician and the Executive shall select one physician, and the
two physicians shall attempt to mutually agree upon such physical or mental disability or infirmity. If the two physicians cannot agree, then the two physicians shall jointly select a third physician, whose opinion on such physical or mental
disability or infirmity shall control. 
 (d) Notice of Termination. Any termination of employment by the Company or the Executive
shall be communicated by a written “Notice of Termination” to the other party hereto given in accordance with Section 27 of this Agreement. In the event of a termination by 

  
 7 

 
the Company for Cause, or by the Executive for Good Reason, the Notice of Termination shall (i) indicate the specific termination provision in this Agreement relied upon, (ii) set forth
in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated and (iii) specify the date of termination, which date shall not be more than 30 days
after the giving of such notice, provided that the date of termination will not occur before the expiration of any applicable cure period. The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance
which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company, respectively, hereunder or preclude the Executive or the Company, respectively, from asserting such fact or circumstance in enforcing
the Executive’s or the Company’s rights hereunder. 
 (e) Resignation from Directorships and Officerships. The termination
of the Executive’s employment for any reason shall constitute the Executive’s resignation from (i) any director, officer or employee position the Executive has with the Company or any of its subsidiaries and (ii) all fiduciary
positions the Executive holds with respect to any employee benefit plans or trusts established by the Company; provided, that in the event the Executive’s employment is terminated following the Executive’s successful completion of the
Executive’s role, as reasonably determined by the Board in its sole discretion, then he will not be required to resign as a member of the Board unless otherwise determined by the Company. The Executive agrees that this Agreement shall serve as
written notice of resignation in this circumstance. 
 (f) Section 280G “Parachute Payments”. Notwithstanding any
provision of this Agreement to the contrary, if the Executive becomes entitled to payments and/or benefits provided by this Agreement or any other amounts in the nature of compensation, whether alone or together with other payments or benefits that
the Executive receives or realizes or is then entitled to receive or realize from the Company or any of its affiliates or any other person whose actions result in a change of ownership or effective control of the Company, and such payments and/or
benefits would constitute an “excess parachute payment” within the meaning of Section 280G of the Code, such payments and/or benefits will be reduced (the “280G Reduction”) to the extent necessary so that no portion of the
Executive’s payments or benefits will be subject to the excise tax imposed by Section 4999 of the Code or any interest or penalties are incurred by the Executive with respect to such excise tax (such excise tax, together with any such
interest and penalties, are hereinafter collectively referred to as the “Excise Tax”). Notwithstanding the foregoing, the 280G Reduction will be made if and only if all “parachute payments” (within the meaning of Code
Section 280G and associated regulations) do not exceed 110% of the maximum amount (the “280G Limit”) of payments and benefits that could be payable to the Executive so that no portion of Executive’s payments or benefits
will be subject to the Excise Tax. Any 280G Reduction pursuant to this paragraph shall be effectuated by reducing the payments and benefits hereunder in the following order: (A) any severance payments due pursuant to Section 5, with later
payments being reduced first, (B) the waiver of accelerated vesting of equity awards, with awards having a later vesting date being reduced first, (C) the benefit continuation pursuant to Section 5 and (D) all other payments or
benefits, with later payments being reduced first. 
 (g) No Further Rights. Except as explicitly provided in this Section 5, the
Executive shall have no rights under this Agreement to receive any compensation or benefits after termination or resignation of employment. 

  
 8 

 6. Confidentiality. 

(a) Confidential Information. 

(i) Definitions. For purposes of Sections 6 through 16, the terms set forth below shall have the following meanings: 

“Business” means manufacturing, designing, distributing, marketing or selling plastics manufacturing
equipment, plastics manufacturing equipment components including hot runner systems, mold components or aftermarket parts or services, or industrial machining chemicals, or any other business engaged in by the Company or any of its subsidiaries
within twelve (12) months prior to the Executive’s termination of employment by or other service to the Company or any of its subsidiaries. 

“Confidential Information” means the business and financial records, customer and supplier lists, business
contacts, contracts, trade secrets, confidential methods of operations of the Company and its affiliates and other related information, as such exists from time to time during the Executive’s employment by or other service to the Company or any
of its subsidiaries. 
 “Customer” means any Person who: 

(i) has been a customer of the Company at any time during the one year period prior to the termination of the Executive’s
employment; or 
 (ii) has evidenced an intention in writing to purchase Products from the Company at any time during the one
year period prior to the termination of the Executive’s employment, 
 (iii) and with whom the Executive had any
dealings, directly or indirectly, or about whom the Executive had confidential information, during the Executive’s employment. 

“Person” means any natural person, corporation, division of a corporation, partnership, trust, joint venture,
association, firm, company, estate or unincorporated organization. 
 “Products” means the products of the
Business (i) manufactured by the Company within the twelve (12) month period immediately preceding the date of this Agreement (ii) manufactured by the Company during the Executive’s employment (iii) manufactured by the Company in
the twelve (12) months following termination of the Executive’s employment in the normal course of operating, maintaining and expanding the business and (iv) any products that are substitutes for or competitive with the products
referred to in clauses (i), (ii) and (iii). 
 (b) Confidentiality. The Executive recognizes and acknowledges that the
Confidential Information constitutes valuable, special and unique assets of the Company and its affiliates, access to and knowledge of which are essential to the performance of the duties of the 

  
 9 

 
Executive hereunder. The Executive acknowledges that such Confidential Information is not generally known in the trade and that such Confidential Information provides the Company and its
affiliates with a competitive edge in its industry. In that regard, the Executive acknowledges and agrees that the Company and its affiliates have taken and are taking reasonable steps to protect the confidentiality of, and legitimate interest in,
the Confidential Information. The Executive therefore agrees that he will not, during his employment, or after termination of his employment, disclose any of such Confidential Information to any Person for any reason or purpose whatsoever except in
connection with the performance of his duties to the Company and its affiliates, nor shall he make use of any such Confidential Information for his own purposes or for the benefit of any Person except the Company and its affiliates. Confidential
Information shall not include any information which is or becomes publicly known through no action or inaction of the Executive. Notwithstanding the foregoing, in the event that the Executive is requested or required, in connection with any
proceeding by or before a governmental authority, to disclose Confidential Information, the Executive will give the Company prompt written notice of such request or requirement so that the Company or its affiliates may seek a protective order or
other appropriate relief. In the event that such protective order or other remedy is not obtained or the Company waives the right to seek such an order or other remedy, the Executive may, without liability hereunder furnish only that portion of the
Confidential Information which the Executive is legally required to disclose. 
 (c) Confidentiality of Agreement. The Executive
agrees that, except as may be required by applicable law or legal process, during the Term and thereafter, he shall not disclose the terms of this Agreement to any person or entity other than the Executive’s accountants, financial advisors,
attorneys or spouse, provided that such accountants, financial advisors, attorneys and spouse agree not to disclose the terms of this Agreement to any other person or entity except as may be required by applicable law or legal process. 

(d) Exclusive Property. The Executive confirms that all Confidential Information is and shall remain the exclusive property of the
Company or any of its subsidiaries or affiliates (collectively, the “Company Group”). All business records, papers and documents kept or made by the Executive relating to the business of the Company Group shall be and remain the
property of the Company Group. Upon the request and at the expense of the Company Group, the Executive shall promptly make all disclosures, execute all instruments and papers and perform all acts reasonably necessary to vest and confirm in the
Company Group, fully and completely, all rights created or contemplated by this Section 6. 
 7. Noncompetition. While employed
or at any time during the eighteen (18) months following termination of the Executive’s employment for whatever reason and whether with or without cause, the Executive shall not in any manner whatsoever (other than a holding of less than
ten percent (10%) of the shares of a company listed on a public stock exchange in Canada or the United States of America) within North America, either individually or in partnership or jointly or in conjunction with any other Person: 

(a) directly, or indirectly, carry on, engage in or be concerned with or interested in any business that manufactures, sells or distributes the
Products; 

  
 10 

 (b) directly, or indirectly, assist (as principal, beneficiary, director, shareholder, partner,
nominee, executor, trustee, agent, servant, employee, independent contractor, supplier, consultant, lender, guarantor, financier or in any other capacity whatever) any Person to carry on, engage in or be concerned with or interested in any business
that manufactures, sells or distributes the Products; or 
 (c) have any direct or indirect interest or concern (as principal, beneficiary,
director, shareholder, partner, nominee, executor, trustee, agent, servant, employee, consultant, independent contractor or in any other capacity whatever) in or with any Person, if any part of the activities of such Person consists of any business
that manufactures, sells or distributes the Products. 
 8. Non-Solicitation. While employed or at any time during the eighteen
(18) months following termination of the Executive’s employment for whatever reason and whether with or without cause, the Executive shall not in any manner whatsoever (other than a holding of less than ten percent (10%) of the shares
of a company listed on a public stock exchange in Canada or the United States of America), either individually or in partnership or jointly or in conjunction with any other Person: 

(a) directly, or indirectly solicit any Customer; 

(b) directly, or indirectly assist (be it as principal, beneficiary, servant, director, shareholder, partner, nominee, executor, trustee,
agent, employee, independent contractor, supplier, consultant, lender, financier or in any other capacity whatever) any Person directly or indirectly to solicit any Customer; or 

(c) have any direct or indirect interest or concern (be it as principal, beneficiary, director, shareholder, partner, nominee, executor,
trustee, agent, servant, employee, consultant, independent contractor, supplier, creditor or in any other capacity whatever) in or with any Person if any of the activities of which Person consists of soliciting any Customer, 

if such solicitation is, directly or indirectly, intended to result in a sale of any Products to such Customer within North America. 

9. Non-Solicitation of Employees. While employed or at any time during the eighteen (18) months following termination of his
employment, for whatever reason, the Executive shall not, directly or indirectly, hire, solicit or induce to perform services, or attempt to solicit or induce to perform services (as an employee, consultant or otherwise) any individuals who are
employees of the Company or take any actions which are intended to persuade any such employee to leave the employ of the Company, without the prior written consent of the Company. This section shall not apply to solicitations made generally to
individuals through public media and which are not specifically targeted at employees of the Company. 
 10. No Conflicting Agreement.
The Executive represents, warrants and covenants to the Company that (a) the Executive has not taken, and will return or (with the consent of his former employer(s)) destroy without retaining copies, all proprietary and confidential materials
of his former employer(s); (b) the Executive has not used any confidential, proprietary or trade secret information in violation of any contractual or common law obligation 

  
 11 

 
to his former employer(s); (c) except as previously disclosed to the Company in writing, the Executive is not party to any agreement, whether written or oral, that would prevent or restrict
him from engaging in activities competitive with the activities of his former employer(s), from directly or indirectly soliciting any employee, client or customer to leave the employ of, or transfer its business away from, his former employer(s) or,
if the Executive is subject to such an agreement or policy, he has complied with it; and (d) the Executive is not a party to any agreement, whether written or oral, that would be breached by or would prevent or interfere with the execution by
the Executive of this Agreement or the fulfillment by the Executive of the Executive’s obligations hereunder. 
 11.
Nondisparagement. The Executive shall not at any time, directly or indirectly, orally, in writing or through any medium, disparage, defame or assail the reputation, integrity or professionalism of the Company or any of its affiliates,
officers, directors, employees or shareholders. Notwithstanding the foregoing, this prohibition does not apply to statements made in the course of sworn testimony in administrative, judicial or arbitral proceedings. 

12. Return of Documents and Property. Upon the termination of his employment or at such other time that the Company may request, the
Executive shall forthwith return and deliver to the Company, and shall not retain, any originals or copies of, any books, papers or price lists of the Company, customer lists, files, books of account, notes and other documents and data or other
writings, tapes or records of the Company maintained by or in the possession of the Executive (and all of the same are hereby acknowledged and agreed to be the property of the Company). 

13. Inventions and Patents. The Executive hereby assigns to the Company all right, title and interest to all patents and patent
applications, all inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports and all similar or related information (in each case whether or not patentable), all copyrights and copyrightable works, all trade
secrets, confidential information and know-how, and all other intellectual property rights that both (a) are conceived, reduced to practice, developed or made by the Executive while employed by the Company or any of its subsidiaries and
(b) either (i) relate to the Company’s or any of its subsidiaries’ actual or anticipated business, research and development or existing or future products or services, or (ii) are conceived, reduced to practice, developed or
made using any equipment, supplies, facilities, assets or resources of the Company or any of its subsidiaries’ (including but not limited to, any intellectual property rights) (“Work Product”). The Executive shall promptly
disclose such Work Product to the Company and, at the Company’s expense, perform all actions reasonably requested by the Company (whether during or after the period of employment) to establish and confirm the Company’s ownership thereof
(including, without limitation, assignments, consents, powers of attorney, applications and other instruments). 
 14. Covenants
Reasonable. The Executive acknowledges and agrees with the Company that: 
 (a) the covenants in this Agreement are reasonable in the
circumstances and are necessary to protect the Company; 

  
 12 

 (b) the Executive is being provided with the opportunity to receive a substantial financial
benefit as a result of this Agreement; 
 (c) the covenants of the Executive contained in this Agreement were a material inducement for the
Company to enter into this Agreement and the execution and delivery of this Agreement is a condition to the Company’s obligations pursuant to this Agreement; and 

(d) the breach by such Executive of any of the provisions of this Agreement would cause serious and irreparable harm to the Company which could
not adequately be compensated for in damages. 
 15. Certain Remedies. 

(a) Forfeiture/Payment Obligations. In the event the Executive fails to comply with Sections 6 through 13, other than any isolated,
insubstantial and inadvertent failure, the Executive agrees that he will forfeit any amounts not already paid pursuant to Section 5(b)(A)-(C) of this Agreement. 

(b) Injunctive Relief. Without intending to limit the remedies available to the Company Group, including, but not limited to, that set
forth in Section 15(a) hereof, the Executive agrees that a breach of any of the covenants contained in Sections 6 through 13 of this Agreement may result in material and irreparable injury to the Company Group for which there is no adequate
remedy at law, that it will not be possible to measure damages for such injuries precisely and that, in the event of such a breach or threat thereof, any member of the Company Group shall be entitled to seek a temporary restraining order or a
preliminary or permanent injunction, or both, without bond or other security, restraining the Executive from engaging in activities prohibited by the covenants contained in Sections 6 through 13 of this Agreement or such other relief as may be
required specifically to enforce any of the covenants contained in this Agreement. Such injunctive relief in any court shall be available to the Company Group in lieu of, or prior to or pending determination in, any arbitration proceeding. 

16. Defense of Claims. The Executive agrees that, during the Term, and for a period of six years after termination of the
Executive’s employment, upon request from the Company, the Executive will reasonably cooperate with the Company in the defense of any claims or actions that may be made by or against the Company that affect the Executive’s prior areas of
responsibility, except if the Executive’s reasonable interests are adverse to the Company in such claim or action. The Company agrees to promptly pay in advance or reimburse the Executive for, as requested by the Executive, all of the
Executive’s reasonable travel and other direct costs and expenses incurred, or to be reasonably incurred, to comply with the Executive’s obligations under this Section 16, including, but not limited to, legal costs and expenses. 

17. Source of Payments. All payments provided under this Agreement, other than payments made pursuant to a plan which provides
otherwise, shall be paid in cash from the general funds of the Company, and no special or separate fund shall be established, and no other segregation of assets shall be made, to assure payment. The Executive shall have no right, title or interest
whatsoever in or to any investments which the Company may make to aid the Company in meeting its obligations hereunder. To the extent that any person acquires a right to receive payments from the Company hereunder, such right shall be no greater
than the right of an unsecured creditor of the Company. 

  
 13 

 18. Section 409A of the Code. This Agreement is intended to meet the requirements of
Section 409A of the Code, and shall be interpreted and construed consistent with that intent. Notwithstanding any other provision of this Agreement, to the extent that the right to any payment (including the provision of benefits) hereunder
provides for the “deferral of compensation” within the meaning of Section 409A(d)(1) of the Code, if the Executive is a “Specified Employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code on the date of the
Executive’s “Separation from Service” within the meaning of Section 409A(a)(2)(A)(i) of the Code (the “Separation Date”), then no such payment shall be made or commence during the period beginning on the
Separation Date and ending on the date that is six months following the Separation Date or, if earlier, on the date of the Executive’s death. The amount of any payment that would otherwise be paid to the Executive during this period shall
instead be paid to the Executive on the fifteenth day of the first calendar month following the end of the period. 
 19.
Nonassignability; Binding Agreement. 
 (a) By the Executive. This Agreement and any and all rights, duties, obligations or
interests hereunder shall not be assignable or delegable by the Executive. 
 (b) By the Company. This Agreement and all of the
Company’s rights and obligations hereunder shall not be assignable by the Company except as incident to a reorganization, merger or consolidation, sale or transfer of all or substantially all of the assets or the business of the Company. Upon
any such assignment, the Company shall no longer have any rights or obligations under this Agreement. 
 (c) Binding Effect. This
Agreement shall be binding upon, and inure to the benefit of, the parties hereto, any successors to or assigns of the Company and the Executive’s heirs and the personal representatives of the Executive’s estate. 

20. Withholding. Any payments made or benefits provided to the Executive under this Agreement shall be reduced by any applicable
withholding taxes or other amounts required to be withheld by law or contract. 
 21. Amendment; Waiver. This Agreement may not be
modified, amended or waived in any manner, except by an instrument in writing signed by both parties hereto. The waiver by either party of compliance with any provision of this Agreement by the other party shall not operate or be construed as a
waiver of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement. 
 22.
Governing Law and Forum. The Executive and the Company agree that this Agreement and all matters or issues arising out of or relating to the Executive’s employment with the Company shall be governed by the laws of the State of Delaware
applicable to contracts entered into and performed entirely therein. Any action to enforce this Agreement shall be brought solely in the state or federal courts located in the City of Cincinnati, Ohio. 

  
 14 

 23. Survival of Certain Provisions. Unless expressly provided otherwise, the rights and
obligations set forth in this Agreement shall survive any termination or expiration of this Agreement. 
 24. Entire Agreement; Supersedes
Previous Agreements. This Agreement and the Option Agreement contains the entire agreement and understanding of the parties hereto with respect to the matters covered herein, and supersedes all prior or contemporaneous negotiations, commitments,
agreements and writings with respect to the subject matter hereof, all such other negotiations, commitments, agreements and writings shall have no further force or effect, and the parties to any such other negotiation, commitment, agreement or
writing shall have no further rights or obligations thereunder. 
 25. Counterparts. This Agreement may be executed by either of the
parties hereto in counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument. 

26. Headings. The headings of sections herein are included solely for convenience of reference and shall not control the meaning or
interpretation of any of the provisions of this Agreement. 
 27. Notices. All notices or communications hereunder shall be in
writing, addressed as follows: 
 To the Company: 

Milacron Holdings Inc. 
 3010
Disney Street 
 Cincinnati, OH 45209 

Attn.: Thomas Goeke 
 Email:
tom_goeke@milacron.com 
 Facsimile: (513) 487-5086 

with a copy to: 
 Weil,
Gotshal & Manges LLP 
 767 Fifth Avenue 

New York, New York 10153 

Attention: David M. Blittner, Esq. 

Email: david.blittner@weil.com 

Facsimile: (212) 310-8007 

To the Executive: 
 John
Gallagher 
 2200 Vaquero Club Drive 

Westlake, Texas 
 Email:
gallagj@yahoo.com 
 Facsimile: (214) 707-1647 

  
 15 

 With a copy to: 

Morgan, Lewis & Bockius LLP 

1701 Market Street 
 Philadelphia,
Pennsylvania 19103 
 Attention: Joseph E. Ronan, Jr. 

Email: jronan@morganlewis.com 

Facsimile: (215) 963-5001 

All such notices shall be conclusively deemed to be received and shall be effective (i) if sent by hand delivery or nationally recognized
courier, upon receipt or (ii) if sent by electronic mail or facsimile, upon receipt by the sender of such transmission. 

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK 

  
 16 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be signed by its officer pursuant to
the authority of its Board, and the Executive has executed this Agreement, as of the day and year first written above. 
  

			
	MILACRON HOLDINGS INC.
		
	By:		 /s/ Tom Goeke

			 Name: Tom Goeke
 Title: President &
CEO

	
	THE EXECUTIVE
	
	 /s/ John Gallagher

	John Gallagher
	
	Dated:   4/12/14

 Exhibit A 

GENERAL RELEASE OF CLAIMS 

This General Release of all Claims (this “Agreement”) is entered into by John Gallagher (the “Executive”)
and Milacron Holdings Inc. (the “Company”), effective as of             , in connection with the termination of the Executive’s employment with the Company as
of            . 
 In consideration of the promises set forth in the Employment
Agreement between the Executive and the Company, dated April             , 2014 (the “Employment Agreement”), the Executive and the Company agree as follows: 

1. Return of Property. All Company files, access keys and codes, desk keys, ID badges, computers, records, manuals, electronic devices,
computer programs, papers, electronically stored information or documents, telephones and credit cards, and any other property of the Company in the Executive’s possession must be returned no later than the date of the Executive’s
termination from the Company; provided, that, the Executive may keep one copy of such items as he may reasonably expect to use to protect his rights under this Agreement. 

2. General Release and Waiver of Claims. 

(a) Release. In consideration of the payments and benefits provided to the Executive under the Employment Agreement and after
consultation with counsel, the Executive and each of the Executive’s respective heirs, executors, administrators, representatives, agents, insurers, successors and assigns (collectively, the “Releasors”) hereby irrevocably and
unconditionally release and forever discharge the Company, its subsidiaries and affiliates and each of their respective officers, employees, directors, shareholders and agents (“Releasees”) from any and all claims, actions, causes
of action, rights, judgments, obligations, damages, demands, accountings or liabilities of whatever kind or character (collectively, “Claims”), including, without limitation, any Claims under any federal, state, local or foreign
law, that the Releasors may have, or in the future may possess, arising out of (i) the Executive’s employment relationship with and service as an employee, officer or director of the Company or any subsidiaries or affiliated companies and
the termination of such relationship or service, and (ii) any event, condition, circumstance or obligation that occurred, existed or arose on or prior to the date hereof; provided, however, that the Executive does not release, discharge or
waive any rights to (A) payments and benefits provided under the Employment Agreement, whether or not contingent upon the execution by the Executive of this Agreement (B) any indemnification rights the Executive may have under the
Employment Agreement, in accordance with the Company’s governance instruments or under any director and officer liability insurance maintained by the Company with respect to liabilities arising as a result of the Executive’s service as an
officer and employee of the Company and (C) any rights that that the Executive may have as an equityholder of the Company. This Section 2(a) does not apply to any Claims that the Releasors may have as of the date the Executive signs
this Agreement arising under the Federal Age Discrimination in Employment Act of 1967, as amended, and the applicable rules and regulations promulgated thereunder (“ADEA”). Claims arising under ADEA are addressed in
Section 2(b) of this Agreement. 

  
 1 

 (b) Specific Release of ADEA Claims. In further consideration of the payments and benefits
provided to the Executive under the Employment Agreement, the Releasors hereby unconditionally release and forever discharge the Releasees from any and all Claims arising under ADEA that the Releasors may have as of the date the Executive signs this
Agreement. By signing this Agreement, the Executive hereby acknowledges and confirms the following: (i) the Executive was advised by the Company in connection with his termination to consult with an attorney of his choice prior to signing this
Agreement and to have such attorney explain to the Executive the terms of this Agreement, including, without limitation, the terms relating to the Executive’s release of claims arising under ADEA, and the Executive has in fact consulted with an
attorney; (ii) the Executive was given a period of not fewer than 21 days to consider the terms of this Agreement and to consult with an attorney of his choosing with respect thereto; (iii) the Executive knowingly and voluntarily accepts
the terms of this Agreement; and (iv) the Executive is providing this release and discharge only in exchange for consideration in addition to anything of value to which the Executive is already entitled. The Executive also understands that he
has seven days following the date on which he signs this Agreement within which to revoke the release contained in this paragraph, by providing the Company with a written notice of his revocation of the release and waiver contained in this
paragraph. 
 (c) No Assignment. The Executive represents and warrants that he has not assigned any of the Claims being released under
this Agreement. The Company may assign this Agreement, in whole or in part, to any affiliated company or subsidiary of, or any successor in interest to the Company. 

3. Proceedings. 
 (a)
General Agreement Relating to Proceedings. The Executive has not filed, and except as provided in Sections 3(b) and 3(c), the Executive agrees not to initiate or cause to be initiated on his behalf, any complaint, charge, claim or
proceeding against the Releasees before any local, state or federal agency, court or other body relating to his employment or the termination of his employment, other than with respect to the obligations of the Company to the Executive under the
Employment Agreement (each, individually, a “Proceeding”), and agrees not to participate voluntarily in any Proceeding. The Executive waives any right he may have to benefit in any manner from any relief (whether monetary or
otherwise) arising out of any Proceeding. 
 (b) Proceedings Under ADEA. Section 3(a) shall not preclude the Executive
from filing any complaint, charge, claim or proceeding challenging the validity of the Executive’s waiver of Claims arising under ADEA (which is set forth in Section 2(b) of this Agreement). However, both the Executive and the Company
confirm their belief that the Executive’s waiver of claims under ADEA is valid and enforceable, and that their intention is that all claims under ADEA will be waived. 

(c) Certain Administrative Proceedings. In addition, Section 3(a) shall not preclude the Executive from filing a charge with
or participating in any administrative investigation or proceeding by the Equal Employment Opportunity Commission or another Fair Employment Practices agency. The Executive is, however, waiving his right to recover money in connection with any such
charge or investigation. The Executive is also waiving his right to recover money in connection with a charge filed by any other entity or individual, or by any federal, state or local agency. 

  
 2 

 4. Remedies. In the event the Executive initiates or voluntarily participates in any
Proceeding in violation of this Agreement, or if he fails to abide by any of the terms of this Agreement or his post-termination obligations contained in the Employment Agreement, or if he revokes the ADEA release contained in paragraph 2(b) within
the seven-day period provided under paragraph 2(b), the Company may, in addition to any other remedies it may have and to the extent permitted by applicable law, reclaim any amounts paid to him under the termination provisions of the Employment
Agreement or terminate any benefits or payments that are subsequently due under the Employment Agreement, without waiving the release granted herein. The Executive acknowledges and agrees that the remedy at law available to the Company for breach of
any of his post-termination obligations under the Employment Agreement or his obligations under paragraphs 2 and 3 herein would be inadequate and that damages flowing from such a breach may not readily be susceptible to measurement in monetary
terms. Accordingly, the Executive acknowledges, consents and agrees that, in addition to any other rights or remedies that the Company may have at law or in equity or as may otherwise be set forth in the Employment Agreement, the Company shall be
entitled to seek a temporary restraining order or a preliminary or permanent injunction, or both, without bond or other security, restraining the Executive from breaching his post-termination obligations under the Employment Agreement or his
obligations under paragraphs 2 and 3 herein. Such injunctive relief in any court shall be available to the Company, in lieu of, or prior to or pending determination in, any arbitration proceeding. 

The Executive understands that by entering into this Agreement he shall be limiting the availability of certain remedies that he may have
against the Company and limiting also his ability to pursue certain claims against the Company. 
 5. Severability Clause. In the
event that any provision or part of this Agreement is found to be invalid or unenforceable, only that particular provision or part so found, and not the entire Agreement, shall be inoperative. 

6. Nonadmission. Nothing contained in this Agreement shall be deemed or construed as an admission of wrongdoing or liability on the part
of the Company or the Executive. 
 7. Governing Law and Forum. The Executive and the Company agree that this Agreement and all
matters or issues arising out of or relating to the Executive’s employment with the Company shall be governed by the laws of the State of Delaware applicable to contracts entered into and performed entirely therein. Any action to enforce this
Agreement shall be brought solely in the state or federal courts located in the City of Cincinnati, Ohio. 

  
 3 

 8. Notices. All notices or communications hereunder shall be in writing, addressed as
follows: 
 To the Company: 

Milacron Holdings Inc. 
 3010
Disney Street 
 Cincinnati, OH 45209 

Attn.: Thomas Goeke 
 Email:
tom_goeke@milacron.com 
 Facsimile: (513) 487-5086 

with a copy to: 
 Weil,
Gotshal & Manges LLP 
 767 Fifth Avenue 

New York, New York 10153 

Attention: David M. Blittner, Esq. 

Email: david.blittner@weil.com 

Facsimile: (212) 310-8007 

To the Executive: 
 John
Gallagher 
 2200 Vaquero Club Drive 

Westlake, Texas 
 Email:
gallagj@yahoo.com 
 Facsimile: (214) 707-1647 

With a copy to: 
 Morgan,
Lewis & Bockius LLP 
 1701 Market Street 

Philadelphia, Pennsylvania 19103 

Attention: Joseph E. Ronan, Jr. 

Email: jronan@morganlewis.com 

Facsimile: (215) 963-5001 

All such notices shall be conclusively deemed to be received and shall be effective (i) if sent by hand delivery or nationally recognized
courier, upon receipt or (ii) if sent by electronic mail or facsimile, upon receipt by the sender of such transmission. 
 THE
EXECUTIVE ACKNOWLEDGES THAT HE HAS READ THIS AGREEMENT AND THAT HE FULLY KNOWS, UNDERSTANDS AND APPRECIATES ITS CONTENTS, AND THAT HE HEREBY EXECUTES THE SAME AND MAKES THIS AGREEMENT AND THE RELEASE AND AGREEMENTS PROVIDED FOR HEREIN VOLUNTARILY
AND OF HIS OWN FREE WILL. 

  
 4 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first set forth
above. 
  

			
	 MILACRON HOLDINGS INC.

		
	 By:
		  

			 Name:

			 Title:

	
	 THE EXECUTIVE

	
	  

John Gallagher

	
	 Dated:
                                         
                       

  
 5 

 Exhibit B 

NONQUALIFIED STOCK OPTION AWARD AGREEMENT 

Attached hereto. 

 MCRON ACQUISITION CORP. 

2012 EQUITY INCENTIVE PLAN 

NONQUALIFIED STOCK OPTION AWARD AGREEMENT 

THIS AGREEMENT (this “Award Agreement”) is made effective as of April [•], 2014 (the “Date of
Grant”) by and between Mcron Acquisition Corp., a Delaware corporation (the “Company”), and John Gallagher (the “Participant”). Capitalized terms not otherwise defined herein shall have
the meanings set forth in the Mcron Acquisition Corp. 2012 Equity Incentive Plan (the “Plan”). 
 R E
C I T A L S: 
 WHEREAS, the Committee has determined that it would be in the best interests of
the Company and its stockholders to grant the option provided for herein to the Participant pursuant to the Plan and the terms set forth herein; and 

WHEREAS, the Participant is an employee of the Company or one of its subsidiaries. 

NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows: 

1. Grant of the Option. The Company hereby grants to the Participant the right and option to purchase, on the terms and conditions set
forth in the Plan and this Award Agreement, all or any part of an aggregate of 5,500 Shares (the “Option”) at an Option Price of $1,000 per Share, which is the per Share Fair Market Value on the Date of Grant. Fifty percent
(50%) of the Option shall be subject to time-based vesting criteria (the “Time Option”), and fifty percent (50%) of the Option shall be subject to performance-based vesting criteria (the “Performance
Option”). The Option is intended to be a Nonqualified Stock Option. 
 2. Vesting. The portion of the Option that has
become vested is hereinafter referred to as the “Vested Portion.” Subject to the terms set forth in the Plan, this Award Agreement, and the Employment Agreement, the Option shall vest as follows: 

a. Time Option. 
 i.
General. The Time Option shall vest in four (4) equal installments on each of the first four (4) anniversaries of April 15, 2014 (each such anniversary, a “Time Vesting Date”), subject to the
Participant’s continued employment by the Company or a Subsidiary through the applicable Time Vesting Date, such that twenty-five percent (25%) of the Time Option shall vest on each Time Vesting Date. 

ii. Initial Public Offering. From and after the date of an IPO, if the average closing trading price for Shares on the exchange on
which the Shares are then listed over any ten (10) day trading period equals or exceeds the Liquidity Threshold Price, then the Time Option shall vest in full immediately following the end of such ten (10) day trading period, subject to
the Participant’s continued employment by the Company or a Subsidiary through the end of such period. 

  
 1 

 iii. Change of Control. Upon or following a Change of Control the Time Option shall vest
in full upon the satisfaction of the vesting criteria in Section 2(b)(i) applicable to the Performance Option, subject to the Participant’s continued employment by the Company or any of its Subsidiaries through the applicable
Measurement Date. 
 b. Performance Option. 

i. Prior to an Initial Public Offering. If prior to the occurrence of an IPO the CCMP Stockholders have received Proceeds on any
Measurement Date resulting in an MOI that is greater than or equal to 2.0, the Performance Option shall vest in full on such Measurement Date, subject to the Participant’s continued employment by the Company or one of its Subsidiaries through
the applicable Measurement Date. 
 ii. Following an Initial Public Offering. From and after the date of an IPO, if the average
closing trading price for Shares on the exchange on which the Shares are then listed over any ten (10) day trading period equals or exceeds the Liquidity Threshold Price, then the Performance Option shall vest in full immediately following the
end of such ten (10) day trading period, subject to the Participant’s continued employment by the Company or a Subsidiary through the end of such period. 

3. Forfeiture; Expiration. 

a. Termination of Employment. Subject to the terms of the Employment Agreement, the Option shall terminate and be forfeited upon or
following the Termination Date as follows: 
 i. In the event that the Participant’s employment is terminated for any reason, any
unvested portion of the Option shall immediately terminate and be forfeited effective the as of the Termination Date. 
 ii. In the event
that the Participant’s employment is terminated for Cause, the Vested Portion shall immediately terminate and be forfeited effective as of the Termination Date. 

iii. In the event that the Participant’s employment is terminated due to death or Disability, the Vested Portion shall terminate and be
forfeited on the earlier of (A) the Expiration Date and (B) one (1) year following the Termination Date. 
 iv. In the event
that the Participant’s employment is terminated due to retirement following the Participant’s attainment of age sixty-five (65), the Vested Portion shall terminate and be forfeited on the earlier of (A) the Expiration Date and
(B) one (1) year following the Termination Date. 

  
 2 

 v. In the event that the Participant’s employment is terminated by the Company without
Cause or, if the Participant has an effective employment agreement, severance agreement, service agreement or other similar agreement with the Company or a Subsidiary that defines “Good Reason” or a like term, by the Participant for Good
Reason, the Vested Portion shall terminate and be forfeited on the earlier of (A) the Expiration Date and (B) ninety (90) days following the Termination Date. 

vi. In the event that the Participant’s employment is terminated by the Participant for any reason other than pursuant to Sections
3(a)(ii)-(v) above, the Vested Portion shall terminate and be forfeited on the earlier of (A) the Expiration Date and (B) sixty (60) days following the Termination Date. 

Notwithstanding anything herein to the contrary, upon the Board’s final determination that the Participant failed to comply with the Restrictive Covenant
Agreement (as defined in Section 11 below), other than any isolated, insubstantial and inadvertent failure to comply, the Participant hereby agrees that (i) any unexercised portion of the Option (both vested and unvested) shall
immediately terminate, (ii) with respect to any portion of the Option that has been exercised, the Company may elect, in its discretion, to (A) repurchase any Shares received by the Participant upon the exercise of the Option in accordance
with Section 2.4 of the Stockholders Agreement, as if such final determination constituted a “Repurchase Triggering Event” under the Stockholders Agreement and/or (B) recover from the Participant the net proceeds received
by the Participant upon the sale of any such Shares (i.e., the amount in excess of the exercise price paid). 
 b. Expiration of Option
Term. Any unexercised portion of the Option shall expire upon the tenth (10th) anniversary of the Date of Grant (the “Expiration Date”). 

4. Period of Exercise. Subject to the provisions of the Plan, this Award Agreement and the Employment Agreement, the Participant may
exercise all or any part of the Vested Portion at any time prior to the earliest to occur of: 
 a. the date the Participant’s
employment with the Company or a Subsidiary is terminated by the employer for Cause; 
 b. the tenth (10th) anniversary of the Date of
Grant; 
 c. the date that occurs one (1) years following the Termination Date upon a termination of employment with the Company or a
Subsidiary due to death, Disability or retirement following the Participant’s attainment of age sixty-five (65); 
 d. the date that
occurs ninety (90) days following the Termination Date upon a termination of employment by the Company or a Subsidiary without Cause or, if the Participant has an effective employment agreement, severance agreement, service agreement or other
similar agreement with the Company or a Subsidiary that defines “Good Reason” or a like term, by the Participant for Good Reason; and 

e. the date that occurs sixty (60) days following the Termination Date upon a termination of employment with the Company or a Subsidiary
for any reason other than by the Company or a Subsidiary with or without Cause, by the Participant for Good Reason, or due to retirement, death or Disability. 

  
 3 

 5. Exercise Procedures. 

a. Notice of Exercise. Subject to Section 4 hereof, the Vested Portion may be exercised by delivering to the Company at its
principal office written notice of intent to so exercise in the form attached hereto as Exhibit A (such notice, a “Notice of Exercise”). Such Notice of Exercise shall be accompanied by payment in full of the aggregate
Option Price for the Shares to be exercised. In the event that the Option is being exercised by the Participant’s representative, the Notice of Exercise shall be accompanied by proof (satisfactory to the Committee) of the representative’s
right to exercise the Option. The aggregate Option Price for the Shares to be exercised may be paid (i) in cash or its equivalent (e.g., by cashier’s check); (ii) prior to an IPO, to the extent permitted by the Committee, in its sole
discretion, (A) in Shares (whether or not previously owned by the Participant) having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased; (B) partly in cash and partly in such Shares (as described in
(A) above); or (C) by reducing the number of Shares otherwise deliverable upon the exercise of the Option by the number of Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased; or
(iii) following an IPO or in connection with a Change of Control transaction, pursuant to clause (A), (B) or (C) of clause (ii) of this Section 5(a), at the election of the Participant, or through the delivery of
irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such sale equal to the aggregate Option Price for the Shares being purchased. In the
event of the Participant’s death, the Vested Portion shall be exercisable by the trustee of any family trust or estate planning entity to which the Option has been transferred, by the executor or administrator of the Participant’s estate,
or the person or persons to whom the Participant’s rights under this Award Agreement shall pass by will or by the laws of descent and distribution, as the case may be. Any heir or legatee of the Participant shall take rights herein granted
subject to the terms and conditions of this Award Agreement and the Plan. 
 b. Stockholder Rights. Except as otherwise provided in
this Agreement, neither the Participant nor the Participant’s representative shall have any rights to dividends, voting rights or other rights of a stockholder with respect to Shares subject to the Option until (i) the Participant has
delivered to the Company a Notice of Exercise for the Option, (ii) the Participant has paid the Option Price for such Shares, (iii) such Shares have been issued, (iv) the Participant has executed a joinder to or has otherwise become a
party to the Stockholders’ Agreement and (v) the Participant has executed such other agreements or certificates that the Committee reasonably determines are necessary to comply with applicable securities laws and other applicable laws.

 6. No Right to Continued Service. The granting of the Option shall impose no obligation on the Company or any Subsidiary to
continue the employment of the Participant and shall not lessen or affect any right that the Company or any Subsidiary may have to terminate the employment of the Participant. 

7. Withholding. The Company shall have the power and the right to deduct or withhold automatically from any payment or Shares
deliverable under this Award Agreement, or to require the Participant to remit to the Company, the minimum statutory amount to satisfy federal, state and local taxes, domestic or foreign, required by law or regulation to be withheld

  
 4 

 
with respect to any taxable event arising as a result of this Award Agreement. The Participant may elect, subject to the approval of the Committee, in its sole discretion, to satisfy the
withholding requirement, in whole or in part, by having the Company withhold shares having a Fair Market Value equal to the minimum statutory total tax that could be imposed in connection with any such taxable event. 

8. Transferability. Unless otherwise determined by the Committee, the Participant shall not be permitted to transfer or assign the
Option except in the event of death (subject to the applicable laws of descent and distribution). 
 9. Adjustment of Option. In the
event of any corporate event or transaction involving the Company, a Subsidiary and/or an Affiliate (including, but not limited to, a change in the Shares of the Company or the capitalization of the Company), such as a merger, consolidation,
reorganization, recapitalization, partial or complete liquidation, reclassification, separation, stock dividend, stock split, reverse stock split, split up, spin-off, combination of Shares, exchange of Shares, dividend in kind, cash dividend,
amalgamation or other like change in capital structure, distribution of any kind or any similar corporate event or transaction, the Committee, to prevent dilution or enlargement of the Participant’s rights under this Award Agreement, shall
choose, in its sole discretion, one or more of the following actions, which the Committee shall take in an equitable manner, (a) substitute or adjust the number and kind of Shares subject to the Option, (b) adjust the Option Price and/or
other value determinations (including performance conditions) applicable to the Option, (c) permit the Participant to participate in the corporate event or transaction, or (d) issue additional Awards or Shares or make cash payments to the
Participant. All adjustments shall be made in good faith compliance with Section 409A. For the avoidance of doubt, management fees payable pursuant to the Advisory Services Agreement shall in no event be considered a dividend for purposes of
this Section 9. 
 10. Effect of Change of Control. Upon the occurrence of a Change of Control after the Date of Grant,
unless otherwise specifically prohibited under applicable laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, the Committee shall choose, in its sole discretion, to make one or more of the
following adjustments in the terms and conditions of any outstanding portions of the Option (which, for the avoidance of doubt, shall exclude any portion of the Option for which a notice of exercise has been received by the Company):
(a) continuation or assumption of the Option under the Plan by the Company (if it is the surviving company or corporation) or by the surviving company or corporation or its parent; (b) substitution by the surviving company or corporation
or its parent of awards with substantially equivalent terms for the Option; (c) accelerated vesting of the Option immediately prior to the occurrence of such event; (d) upon written notice, provision that the Option must be exercised, to
the extent then exercisable, during a reasonable period of time immediately prior to the scheduled consummation of the event or such other period as determined by the Committee (contingent upon the consummation of the event), and at the end of such
period, the Option shall terminate to the extent not so exercised within the relevant period, provided, that, the Participant is able to sell any Shares acquired upon such exercise for cash or liquid securities in the transaction that
causes the Change of Control; (e) cancellation of all or any portion of the Option for consideration (in the form of cash or liquid securities) equal to the excess, if any, of the aggregate Fair Market Value of the Shares subject to the Option
(or the portion thereof being canceled) over the aggregate Option Price with respect to the Option (or the portion thereof 

  
 5 

 being canceled); or (f) in the event of a sale of at least 80% of the outstanding Shares or all or
substantially all of the assets of the Company, cancellation of any unvested portion of the Option for no consideration. For the avoidance of doubt, in the event of a sale of less than 80% of the outstanding Shares or less than substantially all of
the assets of the Company, as applicable, any unvested portions of the Option will remain, subject to clauses (a) through (e) of this Section 10. 

11. Restrictive Covenant Agreement. The Participant agrees to be bound by the Restrictive Covenant Agreement attached hereto as
Exhibit B (the “Restrictive Covenant Agreement”) in consideration of: (a) the Option granted herein; (b) the Participant’s ongoing employment by the Company or a Subsidiary; (c) the importance of
protecting the confidential information of the Company, its Subsidiaries and its Affiliates and their other legitimate interests, including without limitation the valuable confidential information and goodwill that they have developed or acquired;
(d) the Participant being granted access to trade secrets and other confidential information of the Company, its Subsidiaries and its Affiliates; and (e) other good and valuable consideration. 

12. Definitions. For purposes of this Award Agreement: 

a. “Advisory Services Agreement” means that certain Advisory Services and Monitoring Agreement by and among the
Company, CCMP Capital Advisors, LLC and certain other parties, dated as of April 30, 2012, as may be amended from time to time. 
 b.
“Cause” means: 
 i. if the Participant has an effective employment agreement, severance agreement, service
agreement or other similar agreement with the Company or a Subsidiary that defines “Cause” or a like term, the meaning set forth in such agreement at the time of the Participant’s termination of employment and any other conduct or
misconduct that constitutes cause pursuant to the common law or civil law; or, in the absence thereof 
 ii. (A) any act or omission
that constitutes a material breach by the Participant of any of his or her obligations under any agreement with the Company or any of its Subsidiaries or Affiliates or any written lawful policy of the Company, including, without limitation, the
willful and continued failure or refusal of the Participant to substantially perform the duties reasonably required of him or her as an employee of the Company or any of its Subsidiaries or Affiliates; (B) the Participant’s commission of
(x) any felony or similar crime under the laws of a foreign jurisdiction or (y) another crime involving material acts of dishonesty or moral turpitude that relates to the property of the Company or any of its Subsidiaries or Affiliates or
which is or could reasonably be expected to be materially injurious to the financial condition or business reputation of the Company or any of its Subsidiaries or Affiliates; (C) the Participant’s engaging in any willful misconduct which
is or could reasonably be expected to be materially injurious to the financial condition or business reputation of the Company or any of its Subsidiaries or Affiliates; (D) the Participant’s engaging in any intentional act of dishonesty,
violence or threat of violence which is or could reasonably be expected to be materially injurious to the financial condition or business reputation of the Company or any of its Subsidiaries or Affiliates; or (E) any other conduct or misconduct
that constitutes cause pursuant to the common law or civil law. 

  
 6 

 c. “CCMP Stockholders” means CCMP Capital Investors II, L.P., a Delaware
limited partnership, CCMP Capital Investors (Cayman) II, L.P., a Cayman Islands exempted limited partnership, and any successor legal entities to the foregoing Persons as a result of a merger, consolidation or similar reorganization. 

d. “CCMP Stockholders Securities” means the equity securities of the Company acquired by the CCMP Stockholders, whether
acquired before or after the Date of Grant. 
 e. “Change of Control” means any transaction or series of related
transactions, whether or not the Company is a party thereto, (a) in which, after giving effect to such transaction or transactions, the Company equity securities representing in excess of fifty percent (50%) of the voting power of the
Company are owned directly, or indirectly through one or more entities, by any “person” or “group” (as such terms are used in Section 13(d) of the Exchange Act) of persons other than CCMP Stockholders, or (b) in which
there is a sale, lease or other disposition of all or substantially all of the assets of the Company and its subsidiaries on a consolidated basis (including securities of the Company’s directly or indirectly owned subsidiaries (if any)). 

f. “Disability” has the meaning set forth in the Plan. 

g. “Employment Agreement” means that certain Employment Agreement between the Participant and Milacron Holdings Inc.,
dated April [•], 2014. 
 h. “Fair Market Value” means as of any day, with respect to the Shares: 

i. if the Shares are immediately and freely tradable on a stock exchange or an over-the-counter market, the closing price per Share on the
preceding day, or if no trades were made on such date, the immediately preceding day on which trades were made; 
 ii. if there is a pending
transaction in which the Shares of the Company are valued and a definitive agreement for such pending transaction has been entered into by the Company, the per Share value in such valuation; or 

iii. if neither (i) nor (ii) applies, the fair value per Share as determined in good faith by the Board and, for the purpose of
determining the Option Price or grant price of an Award, consistent with the principles of Section 409A of the Code. 
 i.
“Good Reason” means, if the Participant has an effective employment agreement, severance agreement, service agreement or other similar agreement with the Company or a Subsidiary that defines “Good Reason” or a like
term, the meaning set forth in such agreement at the time of the Participant’s termination of employment. 
 j.
“IPO” has the meaning set forth in the Stockholders’ Agreement. 
 k. “Liquidity Threshold
Price” means, at any time, the lowest average closing trading price for Shares over any ten (10) day trading period that, when multiplied by the number of the CCMP Stockholder Securities then held by the CCMP Stockholders and then
added to the Proceeds received by the CCMP Stockholders, would yield an MOI that is greater than or equal to 2.0. 

  
 7 

 l. “Measurement Date” means any date upon which Proceeds are received by
the CCMP Stockholders. 
 m. “MOI” means, as of any Measurement Date, the quotient obtained by dividing (i) the
sum of Proceeds received on such Measurement Date and all prior Measurement Dates, by (ii) the Principal Investment. 
 n.
“Principal Investment” means the sum, without duplication, of: (i) the aggregate consideration paid by the CCMP Stockholders to acquire the CCMP Stockholders Securities, plus (ii) the amount of cash and the value
(as determined by the Board in good faith) of any property contributed by the CCMP Stockholders to the Company, whether contributed before or after the Date of Grant. 

o. “Proceeds” means, without duplication, all pre-tax: (i) cash proceeds actually received by the CCMP
Stockholders from the disposition of the CCMP Stockholders Securities, net of Unreimbursed Transaction Expenses; (ii) cash dividends and other cash distributions actually received by the CCMP Stockholders in respect of the CCMP Stockholders
Securities; and (iii) the fair market value of any non-cash consideration (including but not limited to marketable securities) received in exchange for or in respect of the CCMP Stockholders Securities (net of Unreimbursed Transaction
Expenses). Proceeds shall exclude any amounts payable pursuant to the Advisory Services Agreement. 
 p. “Stockholders’
Agreement” means that certain Mcron Acquisition Corp. Stockholders’ Agreement, dated April 30, 2012, entered into by and among the Company and the stockholders listed on the signature pages thereto or become party thereto, as
may be amended from time to time. 
 q. “Termination Date” means the last day of active employment and does not
include any period of non-working notice or any period for which pay in lieu of notice, termination pay, severance pay or any other monies in relation to the cessation of employment are paid. 

r. “Unreimbursed Transaction Expenses” means all reasonable legal, accounting and investment banking fees, other than
amounts paid to the CCMP Stockholders and their Affiliates, that are not reimbursed by unrelated third parties. 
 13. Eligibility.
The Participant is one of the following as indicated on Exhibit C hereto: 
 a. an “accredited investor” (as defined in
Exhibit C hereto) who has completed Exhibit C hereto as to his status as an “accredited investor,” and such information is true and complete, or 

  
 8 

 b. a non-accredited investor who has, by himself or through a “personal representative”
within the meaning of Rule 501(h) under Regulation D of the Securities Act of 1933, as amended, such knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risks of his or her investment in the
Option and the purchase of Shares upon the exercise of the Option hereunder, and the Participant is capable of bearing the economic risks of such investment and is able to bear the complete loss of such investment. 

14. Option Subject to Plan. By entering into this Award Agreement, the Participant agrees and acknowledges that the Participant has
received and read a copy of the Plan. The Option is subject to the terms and conditions of the Plan. Notwithstanding the foregoing, in the event of a conflict between any term hereof and a term of the Plan, the applicable term of this Award
Agreement shall govern and prevail. 
 15. Stockholders’ Agreement; Conditions and Restrictions on Shares. Shares received upon
the exercise of the Option shall be subject to all of the terms and conditions of the Stockholders’ Agreement, including all transfer restrictions and repurchase rights set forth therein. The Option may not be exercised prior to the
Participant’s execution of a joinder to the Stockholders’ Agreement if the Participant is not a party to the Stockholders’ Agreement prior to any such exercise. The certificates for Shares may include any legend that the Committee
deems appropriate to reflect any conditions and restrictions applicable to such Shares. 
 16. Choice of Law. This Award Agreement,
and all claims or causes of action or other matters that may be based upon, arise out of or relate to this Award Agreement, shall be governed by and construed in accordance with the laws of the State of Delaware, excluding any conflict- or
choice-of-law rule or principle that might otherwise refer construction or interpretation thereof to the substantive laws of another jurisdiction. 

17. Consent to Jurisdiction. The Company and the Participant, by their execution hereof, (a) hereby irrevocably submit to the
exclusive jurisdiction of the state and federal courts in the State of Delaware for the purposes of any claim or action arising out of or based upon this Award Agreement or relating to the subject matter hereof; (b) hereby waive, to the extent
not prohibited by applicable law, and agree not to assert by way of motion, as a defense or otherwise, in any such claim or action, any claim that they are not subject personally to the jurisdiction of the above-named courts, that their property is
exempt or immune from attachment or execution, that any such proceeding brought in the above-named court is improper or that this Award Agreement or the subject matter hereof may not be enforced in or by such court; and (c) hereby agree not to
commence any claim or action arising out of or based upon this Award Agreement or relating to the subject matter hereof other than before the above-named courts or to make any motion or take any other action seeking or intending to cause the
transfer or removal of any such claim or action to any court other than the above-named courts whether on the grounds of inconvenient forum or otherwise. The Company and the Participant hereby consent to service of process in any such proceeding and
agree that service of process by registered or certified mail, return receipt requested, at the address specified pursuant to Section 20, is reasonably calculated to give actual notice. 

18. WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND
COVENANTS THAT HE, SHE OR IT SHALL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN 

  
 9 

 
ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AWARD
AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY
THE OTHER PARTY HERETO THAT THIS SECTION 18 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH HE, SHE OR IT IS RELYING AND SHALL RELY UPON IN ENTERING INTO THIS AWARD AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS
SECTION 18 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF HIS, HER OR ITS RIGHT TO TRIAL BY JURY. 

19. Shares Not Registered. Shares shall not be issued pursuant to this Award Agreement unless the issuance and delivery of such Shares
comply with (or are exempt from) all applicable requirements of law, including, without limitation, the Securities Act of 1933, as amended, the rules and regulations promulgated thereunder, state securities laws and regulations and the regulations
of any stock exchange or other securities market on which the Company’s securities may then be traded. Except as otherwise provided in the Stockholders’ Agreement, the Company shall not be obligated to file any registration statement under
any applicable securities laws to permit the purchase or issuance of any Shares, and accordingly, any certificates for Shares may have an appropriate legend or statement of applicable restrictions endorsed thereon. If the Company deems it necessary
to ensure that the issuance of Shares under this Award Agreement is not required to be registered under any applicable securities laws, the Participant shall deliver to the Company an agreement containing such representations, warranties and
covenants as the Company may reasonably require. 
 20. Notices. Any notice or other communication provided for herein or given
hereunder to a party hereto must be in writing and shall be deemed to have been given (a) when personally delivered or delivered by facsimile transmission with confirmation of delivery or (b) upon delivery after deposit with Federal
Express or similar overnight courier service. A notice shall be addressed to the Company at its principal executive office, attention General Counsel, and to the Participant at the address that he/she most recently provided to the Company. 

21. Entire Agreement. This Award Agreement, including the exhibits attached hereto, the Plan and the Stockholders’ Agreement
constitute the entire agreement and understanding among the parties hereto in respect of the subject matter hereof and supersede all prior and contemporaneous arrangements, agreements and understandings, whether oral or written and whether express
or implied, and whether in term sheets, presentations or otherwise, among the parties hereto, or between any of them, with respect to the subject matter hereof. 

22. Amendment; Waiver. No amendment or modification of any term of this Award Agreement shall be effective unless signed in writing by
or on behalf of the Company and the Participant. No waiver of any breach or condition of this Award Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature. 

  
 10 

 23. Successors and Assigns; No Third-Party Beneficiaries. The provisions of this Award
Agreement shall inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon the Participant and the Participant’s heirs, successors, legal representatives and permitted assigns. Nothing in this Award
Agreement, express or implied, is intended to confer on any person other than the Company and the Participant, and their respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities
under or by reason of this Award Agreement. 
 24. Signature in Counterparts. This Award Agreement may be signed in counterparts, each
of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 
 [signature
page follows] 

  
 11 

 IN WITNESS WHEREOF, the parties hereto have executed this Award Agreement. 

 

			
			 Mcron Acquisition Corp.
  

	By:		  

	Name:		  

	Title:		  

  

			
	Agreed and acknowledged as of the date first above written:
	  
 Signature:
		  

	Name:		  

 EXHIBIT A 

NOTICE OF EXERCISE 
 Mcron Acquisition
Corp. 
 3010 Disney Street 
 Cincinnati, Ohio 45209 

Attention: General Counsel
                                         
                                         
                          Date of Exercise:
                             

Ladies & Gentlemen: 
 1. Exercise of
Option. This constitutes notice to Mcron Acquisition Corp. (the “Company”) that pursuant to my Nonqualified Stock Option Award Agreement, dated             (the
“Award Agreement”), I elect to purchase the number of Shares set forth below for the price set forth below. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Award
Agreement. By signing and delivering this notice to the Company, I hereby acknowledge that I am the holder of the Option exercised by this notice and have full power and authority to exercise the same. 

 

							
			Number of Shares as to				
			which Option is exercised				
			(“Optioned Shares”):		  
		
				
			Shares to be issued in name of:		  
		
				
			Date of Grant:		  
		
				
			Total exercise price:		  
		

 2. Delivery of Payment. With this notice, I hereby deliver to the Company the full exercise price of the
Optioned Shares and any and all withholding taxes due in connection with the exercise of my Option, or I have otherwise satisfied such requirements. 

3. Rights as Stockholder. While the Company shall endeavor to process this notice in a timely manner, I acknowledge that until the
issuance of the Optioned Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) and my satisfaction of any other conditions imposed by the Committee pursuant to the Plan or as
set forth in the Award Agreement, no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to such shares, notwithstanding the exercise of my Option. No adjustment shall be made for a dividend or other
right for which the record date is prior to the date of issuance of the Optioned Shares. 
 4. Interpretation. Any dispute regarding
the interpretation of this notice shall be submitted promptly by me or by the Company to the Committee. The resolution of such a dispute by the Committee shall be final and binding on all parties. 

  
 1 

 5. Entire Agreement. The Plan and the Award Agreement under which the Optioned Shares were
granted are incorporated herein by reference, and together with this notice constitute the entire agreement of the parties with respect to the subject matter hereof. 

Very truly yours, 
  

			
	Signature:	 	 
	Name:	 	 
	Social Security Number:	 	 

  
 2 

 EXHIBIT B 

RESTRICTIVE COVENANT AGREEMENT 

THIS AGREEMENT (this “Restrictive Covenant Agreement”) is made effective as of the Date of Grant by and between the
Company and the Participant. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Nonqualified Stock Option Award Agreement to which this Restrictive Covenant Agreement is attached as Exhibit “B” (the
“Award Agreement”). 
 R E C I T A L S: 

WHEREAS, the Company and the Participant have entered into the Award Agreement; 

AND WHEREAS the Award Agreement is conditional on the Participant entering into this Restrictive Covenant Agreement; 

NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows: 

1. Definitions. For purposes of this Restrictive Covenant Agreement: 

a. “Business” means manufacturing, designing, distributing, marketing or selling plastics manufacturing equipment,
plastics manufacturing equipment components including hot runner systems, mold components or aftermarket parts or services, or industrial machining chemicals, or any other business engaged in by the Company or any if its Subsidiaries within twelve
(12) months prior to the Participant’s termination of employment by or other service to the Company or any of its Subsidiaries. 

b. “Confidential Information” means the business and financial records, customer and supplier lists, business contacts,
contracts, trade secrets, confidential methods of operations of the Company and its affiliates and other related information, as such exists from time to time during the Participant’s employment by or other service to the Company or any of its
Subsidiaries. 
 c. “Customer” means any Person who: 

i. has been a customer of the Company at any time during the one year period prior to the termination of the Participant’s employment; or

 ii. has evidenced an intention in writing to purchase Products from the Company at any time during the one year period prior to the
termination of the Participant’s employment, 
 and with whom the Participant had any dealings, directly or indirectly, or about whom the Participant
had confidential information, during the Participant’s employment. 

  
 1 

 d. “Person” means any natural person, corporation, division of a
corporation, partnership, trust, joint venture, association, firm, company, estate or unincorporated organization. 
 e.
“Products” means the products of the Business (i) manufactured by the Company within the one year period immediately preceding the date of this Restrictive Covenant Agreement (ii) manufactured by the Company during
the Participant’s employment (iii) manufactured by the Company in the twelve (12) months following termination of the Participant’s employment in the normal course of operating, maintaining and expanding the business and
(iv) any products that are substitutes for or competitive with the products referred to in clauses (i), (ii) and (iii). 
 2.
Confidentiality. The Participant recognizes and acknowledges that the Confidential Information constitutes valuable, special and unique assets of the Company and its affiliates, access to and knowledge of which are essential to the
performance of the duties of the Participant hereunder. The Participant acknowledges that such Confidential Information is not generally known in the trade and that such Confidential Information provides the Company and its affiliates with a
competitive edge in its industry. In that regard, the Participant acknowledges and agrees that the Company and its affiliates have taken and are taking reasonable steps to protect the confidentiality of, and legitimate interest in, the Confidential
Information. The Participant therefore agrees that he will not, during his employment, or after termination of his employment, disclose any of such Confidential Information to any Person for any reason or purpose whatsoever except in connection with
the performance of his duties to the Company and its affiliates, nor shall he make use of any such Confidential Information for his own purposes or for the benefit of any Person except the Company and its affiliates. Confidential Information shall
not include any information which is or becomes publicly known through no action or inaction of the Participant. Notwithstanding the foregoing, in the event that the Participant is requested or required, in connection with any proceeding by or
before a governmental authority, to disclose Confidential Information, the Participant will give the Company prompt written notice of such request or requirement so that the Company or its affiliates may seek a protective order or other appropriate
relief. In the event that such protective order or other remedy is not obtained or the Company waives the right to seek such an order or other remedy, the Participant may, without liability hereunder furnish only that portion of the Confidential
Information which the Participant is legally required to disclose. 
 3. Non-Competition. While employed or at any time during the
eighteen (18) months following termination of the Participant’s employment for whatever reason and whether with or without cause, the Participant shall not in any manner whatsoever (other than a holding of less than ten percent
(10%) of the shares of a company listed on a public stock exchange in Canada or the United States of America) within North America, either individually or in partnership or jointly or in conjunction with any other Person: 

a. directly, or indirectly, carry on, engage in or be concerned with or interested in any business that manufactures, sells or distributes the
Products; 

  
 2 

 b. directly, or indirectly, assist (as principal, beneficiary, director, shareholder, partner,
nominee, executor, trustee, agent, servant, employee, independent contractor, supplier, consultant, lender, guarantor, financier or in any other capacity whatever) any Person to carry on, engage in or be concerned with or interested in any business
that manufactures, sells or distributes the Products; or 
 c. have any direct or indirect interest or concern (as principal, beneficiary,
director, shareholder, partner, nominee, executor, trustee, agent, servant, employee, consultant, independent contractor or in any other capacity whatever) in or with any Person, if any part of the activities of such Person consists of any business
that manufactures, sells or distributes the Products. 
 4. Non-Solicitation of Customers. While employed or at any time during the
eighteen (18) months following termination of the Participant’s employment for whatever reason and whether with or without cause, the Participant shall not in any manner whatsoever (other than a holding of less than ten percent
(10%) of the shares of a company listed on a public stock exchange in Canada or the United States of America), either individually or in partnership or jointly or in conjunction with any other Person: 

a. directly, or indirectly solicit any Customer; 

b. directly, or indirectly assist (be it as principal, beneficiary, servant, director, shareholder, partner, nominee, executor, trustee, agent,
employee, independent contractor, supplier, consultant, lender, financier or in any other capacity whatever) any Person directly or indirectly to solicit any Customer; or 

c. have any direct or indirect interest or concern (be it as principal, beneficiary, director, shareholder, partner, nominee, executor,
trustee, agent, servant, employee, consultant, independent contractor, supplier, creditor or in any other capacity whatever) in or with any Person if any of the activities of which Person consists of soliciting any Customer, 

if such solicitation is, directly or indirectly, intended to result in a sale of any Products to such Customer within North America. 

5. Non-Solicitation of Employees. While employed or at any time during the eighteen (18) months following termination of his
employment, for whatever reason, the Participant shall not, directly or indirectly, hire, solicit or induce to perform services, or attempt to solicit or induce to perform services (as an employee, consultant or otherwise) any individuals who are
employees of the Company or take any actions which are intended to persuade any such employee to leave the employ of the Company, without the prior written consent of the Company. This section shall not apply to solicitations made generally to
individuals through public media and which are not specifically targeted at employees of the Company. 
 6. Non-Disparagement. The
Participant shall not at any time, directly or indirectly, orally, in writing or through any medium, disparage, defame or assail the reputation, integrity or professionalism of the Company or any of its affiliates, officers, directors, employees or
shareholders. Notwithstanding the foregoing, this prohibition does not apply to statements made in the course of sworn testimony in administrative, judicial or arbitral proceedings. 

  
 3 

 7. Return of Documents and Property. Upon the termination of his employment or at such
other time that the Company may request, the Participant shall forthwith return and deliver to the Company, and shall not retain, any originals or copies of, any books, papers or price lists of the Company, customer lists, files, books of account,
notes and other documents and data or other writings, tapes or records of the Company maintained by or in the possession of the Participant (and all of the same are hereby acknowledged and agreed to be the property of the Company). 

8. Inventions and Patents. The Participant hereby assigns to the Company all right, title and interest to all patents and patent
applications, all inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports and all similar or related information (in each case whether or not patentable), all copyrights and copyrightable works, all trade
secrets, confidential information and know-how, and all other intellectual property rights that both (a) are conceived, reduced to practice, developed or made by the Participant while employed by the Company or any of its Subsidiaries and
(b) either (i) relate to the Company’s or any of its Subsidiaries’ actual or anticipated business, research and development or existing or future products or services, or (ii) are conceived, reduced to practice, developed or
made using any equipment, supplies, facilities, assets or resources of the Company or any of its Subsidiaries’ (including but not limited to, any intellectual property rights) (“Work Product”). The Participant shall promptly
disclose such Work Product to the Company and, at the Company’s expense, perform all actions reasonably requested by the Company (whether during or after the period of employment) to establish and confirm the Company’s ownership thereof
(including, without limitation, assignments, consents, powers of attorney, applications and other instruments). 
 9. Covenants
Reasonable. 
 a. The Participant acknowledges and agrees with the Company that: 

i. the covenants in this Agreement are reasonable in the circumstances and are necessary to protect the Company; 

ii. the Participant is being provided with the opportunity to receive a substantial financial benefit as a result of Award Agreement; 

iii. the covenants of the Participant contained in this Restrictive Covenant Agreement were a material inducement for the Company to enter
into the Award Agreement and the execution and delivery of this Restrictive Covenant Agreement is a condition to the Company’s obligation pursuant to the Award Agreement; and 

iv. the breach by such Participant of any of the provisions of this Restrictive Covenant Agreement would cause serious and irreparable harm to
the Company which could not adequately be compensated for in damages. 
 b. The Participant agrees that the Company shall be entitled to
obtain and the Participant agrees not to oppose a request for, interim, interlocutory and permanent injunctive relief and other equitable relief to prevent a breach or continued breach of the provisions of this Restrictive Covenant Agreement, as
well as an accounting of all profits and benefits that arise 

  
 4 

 out of such violation, which rights and remedies shall be cumulative in addition to any other rights or remedies
to which the Company may be entitled in law. The provisions of this section shall not derogate from any other remedy which the Company may have in the event of such a breach. 

10. Severability. In the event that a court of competent jurisdiction determines that any term or provision of this Restrictive Covenant
Agreement is illegal, invalid or unenforceable in any jurisdiction, such illegality, invalidity or unenforceability of that term or provision will not affect: (a) the legality, validity or enforceability of the remaining terms and provisions of
this Restrictive Covenant Agreement; and (b) the legality, validity or enforceability of such term or provision in any other jurisdiction. Further, to the extent that any provision hereof is deemed unenforceable by virtue of its scope in terms
of territory, length of time, scope of activities or otherwise, but may be made enforceable by limitations or revisions thereon, the parties agree that such limitations or revisions may be made so that the same shall, nevertheless, be enforceable to
the fullest extent permitted by law. 
 11. Notices. Any notice or other communication provided for herein or given hereunder to a
party hereto must be in writing and shall be deemed to have been given (a) when personally delivered or delivered by facsimile transmission with confirmation of delivery or (b) upon delivery after deposit with Federal Express or similar
overnight courier service. A notice shall be addressed to the Company at its principal executive office, attention General Counsel, and to the Participant at the address that he/she most recently provided to the Company. 

12. Entire Agreement. This Restrictive Covenant Agreement and the Employment Agreement constitutes the entire agreement and
understanding among the parties hereto in respect of the subject matter hereof and supersedes all prior and contemporaneous arrangements, agreements and understandings, whether oral or written and whether express or implied, and whether in term
sheets, presentations or otherwise, among the parties hereto, or between any of them, with respect to the subject matter hereof. 
 13.
Amendment; Waiver. No amendment or modification of any term of this Restrictive Covenant Agreement shall be effective unless signed in writing by or on behalf of the Company and the Participant. No waiver of any breach or condition of this
Restrictive Covenant Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature. 

14. Successors and Assigns; No Third-Party Beneficiaries. The provisions of this Restrictive Covenant Agreement shall inure to the
benefit of, and be binding upon, the Company and its successors and assigns. 
 15. Signature in Counterparts. This Restrictive
Covenant Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 

  
 5 

 IN WITNESS WHEREOF, the parties hereto have executed this Restrictive Covenant Agreement. 

 

			
			 Mcron Acquisition Corp.
  

	By:		  

	Name:		  

	Title:		  

  

	
	 Agreed and acknowledged as of the date first above written: 

	
	Signature:                                    
                                         

	Name:                                     
                                         
      

 EXHIBIT C 

ACCREDITED INVESTOR STATUS 

Participant represents and warrants that he is not an “accredited investor” as defined in Rule 501(a) promulgated under
Regulation D of the Securities Act of 1933, as amended (please initial the non-accredited investor election below): 
  

			
	  
		Participant is not an “accredited investor.”
	
	 Participant represents and warrants that he is an “accredited investor” as defined in Rule 501(a) promulgated under Regulation
D of the Securities Act of 1933, as amended, because he meets at least one of the following criteria (please initial each applicable item):

		
	              
		Participant is a natural person whose individual net worth, or joint net worth with his or her spouse, exceeds $1,000,000 at the time of the grant of the Option, excluding the value of the primary residence of such natural person,
calculated by subtracting from the estimated fair market value of the property the amount of debt secured by the property, up to the estimated fair market value of the property; or
		
	  
		Participant is a natural person who had an individual income in excess of $200,000 in each of the two most recent years (2012 and 2013) or joint income with the Participant’s spouse in excess of $300,000 in each of those years
and who reasonably expects to reach the same income level in the current year (2014); or
		
	  
		Participant is a corporation, or similar business trust, partnership or an organization described in Section 501(c)(3) of the Internal Revenue Code, not formed for the specific purpose of acquiring the Option, with total assets
in excess of $5,000,000; or
		
	  
		Participant is either (i) a bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its
individual or fiduciary capacity, (ii) a broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended, (iii) an insurance company as defined in Section 2(13) of the Securities Act,
(iv) an investment company registered under the Investment Company Act of 1940, as amended, or a business development company as defined in Section 2(a)(48) of such Act, (v) a Small Business Investment Company licensed by the U.S.
Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958, (vi) a plan established or maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its
political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000 or (vii) an employee benefit plan within in the meaning of the Employee
Retirement

			
			Income Security Act of 1974, as amended (“ERISA”), if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of ERISA, which plan fiduciary is either a bank, savings and loan
association, insurance company or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons who are accredited investors;
or
		
	  
		Participant is a private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended; or
		
	  
		Participant is a director or executive officer of Mcron Acquisition Corp.; or
		
	  
		Participant is a trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Option, the purchase of which is directed by a sophisticated person as described in Rule 506(b)(2)(ii) of
Regulation D promulgated under the Securities Act; or
		
	  
		Participant is any entity in which all of the equity owners are accredited investors. (Please submit a copy of this page countersigned by each such equity owner if relying on this item).

  
 2EX-10.9

 Exhibit 10.9 

DATED March 20, 2013 

MILACRON UK LIMITED 
 and

 RONALD M. KRISANDA 

EMPLOYMENT AGREEMENT 
  

 

 Table of Contents 

 

							
	1.		 Interpretation
		 	1	  
	2.		 Term
		 	4	  
	3.		 Executive’s warranties and representations
		 	4	  
	4.		 Duties
		 	4	  
	5.		 Place of work
		 	5	  
	6.		 Hours of work
		 	5	  
	7.		 Salary
		 	5	  
	8.		 Expenses
		 	6	  
	9.		 Bonus
		 	6	  
	10.		 Benefits
		 	6	  
	11.		 Pension
		 	7	  
	12.		 Holidays
		 	7	  
	13.		 Incapacity
		 	8	  
	14.		 Outside interests
		 	9	  
	15.		 Confidential information
		 	9	  
	16.		 Intellectual property
		 	10	  
	17.		 Termination with payment in lieu of notice
		 	10	  
	18.		 Termination for cause
		 	11	  
	19.		 Payments on termination
		 	11	  
	20.		 Garden leave
		 	12	  
	21.		 Obligations on termination
		 	13	  
	22.		 Post-termination restrictions
		 	14	  
	23.		 Release and reaffirmation
		 	15	  
	24.		 Disciplinary and grievance procedures
		 	15	  
	25.		 Data protection
		 	15	  
	26.		 Reconstruction and amalgamation
		 	16	  
	27.		 Notices
		 	16	  
	28.		 Entire agreement and variation
		 	17	  
	29.		 Counterparts
		 	17	  
	30.		 Third party rights
		 	17	  
	31.		 Governing law and jurisdiction
		 	17	  

 AGREEMENT made the 20th day of March 2013 

BETWEEN 
  

	(1)	MILACRON UK LIMITED incorporated in England and Wales with company number 04444980 whose registered office is at 100 New Bridge Street, London EC4V 6JA (Company). 

 

	(2)	RONALD M. KRISANDA of Ashbury House, Priory Road, Sunningdale SL5 9RQ, United Kingdom (Executive). 

AGREED TERMS 
  

	1.	INTERPRETATION 

  

	1.1	The definitions and rules of interpretation in this clause 1 apply in this Agreement. 

 Base
Salary: has the meaning given in clause 7.1. 
 Board: the board of directors of Mcron Acquistion Corp., a Delaware, U.S.A.
corporation (including any committee of the board duly appointed by it). 
 Capacity: as agent, consultant, director, employee, owner,
partner, shareholder, investor or in any other capacity. 
 Cause: any of the facts, circumstances or events set out in clauses
18.1.1-18.1.9. 
 CEO: the Chief Executive Officer of Milacron from time to time. 

Commencement Date: 1 April 2013. 

Compensation Payment: an amount equal to six months’ Base Salary less deductions for income tax and employees’ national
insurance contributions. 
 Competing Business: any business which competes or proposes to compete with any business carried on by
Milacron or any Group Company at Termination. 
 Confidential Information: information (whether or not recorded in documentary form,
or stored on any electronic, magnetic or optical disk or memory device) relating to the business, products, affairs and finances, employees or shareholders of Milacron or any Group Company for the time being confidential to Milacron or any Group
Company and trade secrets including, without limitation, technical data, manufacturing processes and know-how relating to the business of Milacron or any Group Company or any of their business 

  
 1 

 
contacts, including in particular (by way of illustration only and without limitation) management accounts, business plans and strategies, pricing strategy, discounts, promotions, profit margins,
supplier identity, supplier contracts, customer identity and ranking, customer contracts, remuneration of employees, market research, marketing and sales information and strategy, budgets, expenditure and order metrics. 

Connected Person: has the meaning given in section 252 Companies Act 2006 (whether or not the Executive is a director). 

Garden Leave: any period during which the Company has exercised its rights under clause 20. 

Good Reason: a material reduction in Base Salary without the Executive’s written consent. 

Group: Milacron and its Subsidiaries and Holding Companies, each of their Subsidiaries and Holding Companies and any other company,
corporation, partnership or other entity in which any Group Company has a shareholding or legal or beneficial ownership interest, in each case from time to time. 

Group Company: any member of the Group from time to time. 

Incapacity: any illness or injury which prevents the Executive from carrying out his duties for more than 90 consecutive days or more
than 180 days in aggregate in any consecutive period of 12 months. 
 Intellectual Property Rights: patents, rights to Inventions,
copyright and related rights, trade marks, trade names and domain names, rights in get-up, rights in goodwill or to sue for passing off, unfair competition rights, rights in designs, rights in computer software, database rights, topography rights,
rights in confidential information (including know-how and trade secrets) and any other intellectual property rights, in each case whether registered or unregistered and including all applications (or rights to apply) for, and renewals or extensions
of, such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world. 

Invention: any invention, idea, discovery, development, improvement or innovation, whether or not patentable or capable of registration,
and whether or not recorded in any medium. 
 Milacron: Milacron LLC, a Delaware, USA, limited liability company. 

Prospective Customer: any person, firm or company with whom the Executive or any other employee of Milacron, the Company or any Group
Company had negotiations during the Relevant Period with a view to such person, firm or company becoming a customer of Milacron, the Company or any Group Company. 

  
 2 

 Release and Reaffirmation Letter: a waiver, release and compromise agreement and a
reaffirmation thereof that are reasonably satisfactory to the Company and that are substantially in the form at Schedule 2. 
 Relevant
Period: the period of 12 months immediately preceding Termination. 
 Restricted Customer: any person, firm, company or other
entity who during the Relevant Period was a customer or was in the habit of dealing with Milacron, the Company or any Group Company. 

Restricted Goods or Services: goods or services of the type produced or provided by Milacron, the Company or any Group Company. 

Restricted Supplier: any person who during the Relevant Period supplied goods or services to Milacron, the Company or any Group Company.

 Subsidiary and Holding Company: in relation to a company mean “subsidiary” and “holding company” as defined in
section 1159 of the Companies Act 2006 and a company shall be treated, for the purposes only of the membership requirement contained in subsections 1159(1)(b) and (c), as a member of another company even if its shares in that other company are
registered in the name of (a) another person (or its nominee), whether by way of security or in connection with the taking of security, or (b) a nominee. 

Termination: the termination of the Executive’s employment with the Company for whatever reason and however arising. 

 

	1.2	The headings in this Agreement are inserted for convenience only and shall not affect its construction. 

  

	1.3	A reference to a particular law is a reference to it as it is in force for the time being taking account of any amendment, extension, or re-enactment and includes any subordinate legislation for the time being in force
made under it. 

  

	1.4	Unless the context otherwise requires, a reference to one gender shall include a reference to the other genders. 

  

	1.5	Unless the context otherwise requires, words in the singular include the plural and in the plural include the singular. 

  

	1.6	The words “include”, “including”, “in particular” or any similar expression will be construed as meaning without limitation. 

 

	1.7	The Schedules are incorporated into and form part of this Agreement. 

  
 3 

	2.	TERM 

  

	2.1	The Executive’s employment shall commence on the Commencement Date and shall continue, subject to the remaining terms of this Agreement, until terminated by either party giving to the other not less than twelve
months’ prior notice in writing, such notice not to be given before the first anniversary of the Commencement Date. 

  

	2.2	The Executive’s period of continuous employment with the Company commenced on the Commencement Date. 

  

	3.	EXECUTIVE’S WARRANTIES AND REPRESENTATIONS 

  

	3.1	The Executive represents and warrants to the Company that: 

  

	3.1.1	by entering into this Agreement or performing any of his obligations under it, including acting as a director, he will not be in breach of any court order or any express or implied terms of any contract, agreement or
other obligation binding on him; 

  

	3.1.2	he has not used and will not use any confidential information or trade secret of any third party in relation to the duties of his employment or the business or affairs of the Company or any Group Company; and

  

	3.1.3	he is entitled to work in the United Kingdom and will immediately notify the Company if he ceases to be so entitled during his employment. 

 

	4.	DUTIES 

  

	4.1	The Executive shall serve as Chief Operating Officer of Milacron and shall support Milacron’s business unit presidents in the role of President of Milacron – Europe. The Executive shall serve in such other
role(s) of equivalent status to which the Board may appoint him from time to time. 

  

	4.2	During his employment the Executive shall: 

  

	4.2.1	report to the CEO in connection with the affairs of Milacron and any Group Company on such matters and at such times as are required; 

 

	4.2.2	carry out such duties for Milacron, the Company and any Group Company, including acting as a director thereof, as the CEO or the Board may require from time to time; 

 

	4.2.3	comply with the articles of association, by-laws or constitutional documents (as amended from time to time) of any Group Company of which he is a director or officer; 

 

	4.2.4	comply with his statutory, fiduciary and common-law duties as a director and senior employee of the Company and any Group Company of which he is a director or officer; 

 

	4.2.5	save where prevented by Incapacity or to the extent that prior written consent of the CEO or the Board has been given to him to do otherwise, devote the whole of his time, attention and abilities to the business of the
Company and any Group Company of which he is a director or officer; 

  
 4 

	4.2.6	faithfully and diligently exercise such powers and perform such duties as may from time to time be assigned to him by the CEO; 

  

	4.2.7	comply with all lawful directions given to him by the Company, the CEO or the Board; 

  

	4.2.8	report his own wrongdoing and any wrongdoing or proposed wrongdoing of any other employee of the Company or any Group Company to the CEO immediately on becoming aware of it or, if the wrongdoing is on the part of the
CEO or any director, to the Board; 

  

	4.2.9	use his best endeavours to promote, protect, develop and extend the business of the Group; and 

  

	4.2.10	comply with any rules, policies and procedures as they apply to any Group Company of which he is a director or with which he is involved during the course of his duties from time to time in force. 

 

	4.3	The Company may appoint another person jointly to perform the Executive’s duties with him if the Executive is placed on Garden Leave or is absent due to Incapacity for an aggregate period exceeding 180 days in
aggregate in any 12 consecutive months. 

  

	5.	PLACE OF WORK 

  

	5.1	The Executive’s normal place of work is at Unit 2, Wildmere Close, Wildmere Road, Banbury, United Kingdom or such other place which the Company may require for the proper performance and exercise of his duties.

  

	5.2	The Executive will travel within the United Kingdom and abroad as may be required for the proper performance of his duties. 

  

	6.	HOURS OF WORK 

  

	6.1	The Executive will work during the Company’s normal business hours and such additional hours as are necessary for the proper performance of his duties. The Executive acknowledges that he shall not receive further
remuneration in respect of such additional hours. 

  

	6.2	The parties agree that the nature of the Executive’s position is such that his working time cannot be measured and, accordingly, that his employment falls within the scope of regulation 20 of the Working Time
Regulations 1998. 

  

	7.	SALARY 

  

	7.1	The Company shall pay the Executive a salary of £315,000 per annum (Base Salary) which shall be inclusive of any fees due to the Executive as a director or officer of the Company or any Group Company.

  

	7.2	The Base Salary shall accrue from day to day and be payable monthly in arrears less deductions for tax, employees’ national insurance contributions and any other relevant deductions on or about the last working day
of each month directly into the Executive’s nominated bank account. 

  
 5 

	7.3	The Executive’s Base Salary shall be reviewed by the Board. The Board is under no obligation to award an increase following a salary review but will not decrease Base Salary without the written consent of the
Executive. There will be no review of Base Salary after notice has been given by either party to terminate his employment. 

  

	7.4	The Company may deduct from Base Salary, or any other sums owed to the Executive, any money owed to the Company or any Group Company by the Executive or overpaid by the Company to the Executive. 

 

	8.	EXPENSES 

 Subject to the Executive complying with such expenses policy as Milacron
operates from time to time, the Company shall reimburse all reasonable expenses wholly, properly and necessarily incurred by the Executive in the course of his duties, subject to production of VAT receipts or other appropriate evidence of payment.

  

	9.	BONUS 

  

	9.1	The Company shall pay the Executive a sign-on bonus of £30,000 within 30 days of the Commencement Date less deductions for tax and employee national insurance contributions. 

 

	9.2	The gross amount of the bonus referred to in clause 9.1 shall be repaid by the Executive to the Company within 30 days if during the 12 twelve months immediately following the Commencement Date the Company terminates
his employment for Cause or the Executive terminates his employment in breach of this Agreement. 

  

	9.3	Subject to clauses 9.4 and 9.5, the Executive shall be eligible to participate in such annual bonus scheme as is established by the Board for executives at his level from time to time. The bonus scheme in which the
Executive shall participate at the Commencement Date is set out in Schedule 1. 

  

	9.4	The Executive shall have no entitlement to any bonus (pro rata or otherwise) in respect of the year in which Termination occurs. 

  

	9.5	Subject to clause 23, where Termination is not for Cause or is with Good Reason the Executive shall be entitled to any bonus for a previous year that has been earned and approved by the Board but not yet paid to the
Executive. Any bonus payable under this clause shall be paid to the Executive at the same time as the relevant bonus is paid to other executives who participate in the scheme (even if after Termination). For the avoidance of doubt, the Executive
shall have no entitlement to any unpaid bonus if his employment terminates for Cause or without Good Reason. 

  

	9.6	Bonus payments shall not be pensionable. 

  

	10.	BENEFITS 

  

	10.1	From the Commencement Date the Executive shall be eligible to participate in the following benefit arrangements: 

  

	10.1.1	private medical insurance for himself, with the option to add family members at his own cost; 

  
 6 

	10.1.2	long term disability insurance providing a benefit of 40% of Base Salary, with an option for the Executive to add additional cover of 20% of Base Salary at his own cost, subject to any cap on benefits from time to time;
and 

  

	10.1.3	life insurance to the value of 100% of Base Salary. 

  

	10.2	Participation in the arrangements referred to in clause 10.1 is subject to: (i) the rules or policy of any insurance provider as amended from time to time; (ii) the terms of any insurance policy of the
relevant insurance provider as amended from time to time; (iii) the Executive and his dependents satisfying the normal underwriting requirements of the relevant insurance provider; (iv) the premium being at a rate which the Board considers
reasonable; and (v) the Board’s absolute discretion to discontinue, vary or amend the schemes at any time by giving notice to the Executive. 

  

	10.3	If any insurance provider refuses for any reason to provide any cover or benefit to the Executive or any of his dependents, no Group Company shall be liable to provide any replacement benefit of the same or similar kind
or to pay any compensation in lieu of such benefit. 

  

	10.4	The Executive shall be entitled to be covered by such directors’ and officers’ insurance as applies to other directors and officers of the Company and Group Companies of which he is a director or officer both
during his employment and for so long after Termination as the Company or the relevant Group Company elects to maintain such insurance. 

  

	11.	PENSION 

  

	11.1	From the Commencement Date, if the Executive makes contributions to a defined contribution pension scheme nominated by him, the Company will make a matching contribution to the scheme on his behalf up to a maximum of
50% of the first 2% of defined contribution eligible earnings based on the 401(a)(17) statutory U.S. earnings limit, or such other amount as the Board may determine from time to time, payable in monthly instalments in arrears provided that:

  

	11.1.1	the scheme nominated by the Executive will be a qualifying scheme for the purposes of section 16 of the Pensions Act 2008; 

  

	11.1.2	the sum of the Company’s and the Executive’s contributions will not exceed the annual allowance set by HM Revenue & Customs from time to time; and 

 

	11.1.3	the Executive will be solely responsible for any tax payable on any pension contributions to the extent that they exceed any annual or lifetime allowance set by HM Revenue & Customs from time to time.

  

	12.	HOLIDAYS 

  

	12.1	The Executive shall be entitled to 25 days’ paid holiday in each holiday year together with the usual public holidays in England. Holiday entitlement shall accrue on a monthly basis. If the Executive’s
employment commences or terminates part way through a holiday year, the Executive’s entitlement during that holiday year shall be calculated on a pro-rata basis rounded up to the nearest day. 

  
 7 

	12.2	Holiday shall be taken at such time or times as shall be approved in advance by the CEO. The Executive shall not without the written consent of the CEO carry forward any accrued but untaken holiday entitlement to a
subsequent holiday year unless the Executive has been unavoidably prevented from taking such holiday during the relevant leave year because of sickness absence or statutory paternity or adoption leave. 

 

	12.3	The Executive shall have no entitlement to any payment in lieu of accrued but untaken holiday except on Termination, in which case, subject to clause 12.4, payment shall be made only in respect of untaken days for the
holiday year in which Termination takes place and shall be calculated as 1/260th of Base Salary for each day. 

  

	12.4	If the Company terminates or would be entitled to terminate his employment for Cause, or if the Executive terminates his employment without Good Reason or in breach of this Agreement, any payment due under clause 12.3
shall be limited to £1. 

  

	12.5	If on Termination the Executive has taken in excess of his accrued holiday entitlement, the Company shall be entitled to recover from the Executive by way of deduction from any payments due to the Executive or otherwise
one day’s pay calculated at 1/260th of Base Salary for each excess day. 

  

	12.6	If either party has served notice to terminate the Executive’s employment, the Company may require the Executive to take any accrued but unused holiday during the notice period or any period of Garden Leave.

  

	13.	INCAPACITY 

  

	13.1	If the Executive is absent from work as a result of illness or injury he shall, subject to complying with the Company’s sickness absence procedures from time to time, be entitled to Base Salary and contractual
benefits under this Agreement during the period of 180 days in aggregate in any 12 consecutive months. Thereafter, any payment to the Executive shall be at the absolute discretion of the Board. 

 

	13.2	The Executive agrees to consent to medical examinations (at the Company’s expense) by a doctor nominated by the Company should the Company so require. The Executive agrees that any report produced in connection
with any such examination may be disclosed to the Board, Milacron and the Company, each of which may discuss the contents of the report with the relevant doctor and with their advisers. 

 

	13.3	The rights of the Company to terminate the Executive’s employment under the terms of this Agreement apply even when such termination may cause the Executive to lose any entitlement to sick pay or any other
benefits. 

  
 8 

	14.	OUTSIDE INTERESTS 

  

	14.1	Subject to his duties under this Agreement, during his employment the Executive will be entitled to hold one non-executive directorship with a company other than a Group Company on condition that: (i) he disclose
to the CEO in advance the identity of the company in question; (ii) such company does not in any way compete with the business of the Company or any Group Company; (iii) the Executive performs his non-executive director duties for that
company during his periods of holiday as permitted under this Agreement; (iv) the non-executive directorship does not in any way interfere with or conflict with the Executive’s duties hereunder; and (v) the Board may at any time and
for any reason require the Executive to resign such non-executive directorship. 

  

	14.2	Other than as permitted under clause 14.3, during his employment the Executive shall not, except as a representative of a Group Company or with the prior written approval of the Board, hold any office or be directly or
indirectly engaged, concerned or have any financial interest in any Capacity, whether paid or unpaid, in any other business, trade, profession or occupation (or the setting up of any business, trade, profession or occupation). 

 

	14.3	Notwithstanding clause 14.1 and without prejudice to his duties under this Agreement, the Executive may during his employment hold an investment by way of shares or other securities of not more than 3% of the total
issued share capital of any company of which the shares are listed or dealt in on a recognised investment exchange and which does not carry on or intend to carry on a business similar to or competitive with any business for the time being carried on
by the Company or any Group Company. 

  

	14.4	The Executive agrees to disclose immediately to the Board any matters relating to his Connected Persons which may be considered to interfere, conflict or compete with the proper performance of the Executive’s
obligations under this Agreement. 

  

	15.	CONFIDENTIAL INFORMATION 

  

	15.1	The Executive acknowledges that in the course of his employment he will have access to Confidential Information and has therefore agreed to accept the restrictions in this clause 15. 

 

	15.2	The Executive shall not (except in the proper course of his duties), either during his employment or at any time after its Termination, use or disclose to any person, company or other organisation whatsoever (and shall
use his best endeavours to prevent the publication or disclosure of) any Confidential Information. This shall not apply to: 

  

	15.2.1	any use or disclosure authorised by the Board or required by law; 

  

	15.2.2	any information which is already in, or comes into, the public domain other than through the Executive’s unauthorised disclosure; or 

 

	15.2.3	any protected disclosure within the meaning of section 43A of the Employment Rights Act 1996. 

  
 9 

	15.3	If before or after Termination the Executive becomes legally obliged to disclose any Confidential Information he shall: (i) if permitted by law, immediately notify the Board specifying as far as possible the
information to be disclosed, the likely recipients and the reason for disclosure; and (ii) furnish only that portion of such Confidential Information or take only such action as is legally required by binding order and shall exercise his
reasonable efforts to obtain reliable assurance that confidential treatment shall be accorded any such Confidential Information. The Company shall promptly pay (upon receipt of invoices and any other documentation as may be requested by the Company)
all reasonable expenses and fees incurred by the Executive, including attorneys’ fees, in connection with his compliance with the immediately preceding sentence. 

 

	16.	INTELLECTUAL PROPERTY 

  

	16.1	The Executive shall give Milacron full written details of all Inventions and of all works embodying Intellectual Property Rights made wholly or partially by him at any time during the course of his employment which
relate to, or are reasonably capable of being used in, the business of the Company or any Group Company. The Executive acknowledges that all Intellectual Property Rights subsisting (or which may in the future subsist) in all such Inventions and
works shall automatically, on creation, vest in the Company absolutely. To the extent that they do not vest automatically, the Executive holds them on trust for the Company. The Executive agrees promptly to execute all documents and do all acts as
may, in the opinion of the Board, be necessary to give effect to this clause 16.1. 

  

	16.2	The Executive hereby irrevocably waives all moral rights under the Copyright, Designs and Patents Act 1988 (and all similar rights in other jurisdictions) which he has or will have in any existing or future works
referred to in clause 16.1. 

  

	16.3	The Executive hereby irrevocably appoints any member of the Board or any director of the Company from time to time to be his attorney to execute and do any such instrument or thing and generally to use his name for the
purpose of giving the Company or its nominee the benefit of this clause 16 and acknowledges in favour of a third party that a certificate in writing signed by any member of the Board Company that any instrument or act falls within the authority
conferred by this clause 16.3 shall be conclusive evidence that such is the case. 

  

	17.	TERMINATION WITH PAYMENT IN LIEU OF NOTICE 

 Notwithstanding clause 2, the Company may in
its absolute discretion at any time on or after the first anniversary of the Commencement Date terminate the Executive’s employment with immediate effect by giving written notice to the Executive and paying the Executive an amount equal to the
Base Salary (as at the date of Termination) that the Executive would have been entitled to receive under this Agreement during the notice period referred to in clause 2 or, if notice has already been given, during the remainder of the notice period.

  
 10 

	18.	TERMINATION FOR CAUSE 

  

	18.1	Notwithstanding any other term of this Agreement, the Company may terminate the Executive’s employment at any time with immediate effect without any liability to make any further payment to the Executive (other
than salary accrued up to Termination) if the Executive: 

  

	18.1.1	is guilty of any gross misconduct affecting the business of the Group or any Group Company; 

  

	18.1.2	commits any serious or repeated breach or non-observance of any of the provisions of this Agreement or the articles of association, by-laws or constitution of the Company or any Group Company of which he is a director;

  

	18.1.3	refuses or neglects to comply with any reasonable and lawful directions of the Board; 

  

	18.1.4	is, in the reasonable opinion of the Board, seriously negligent or incompetent in the performance of his duties; 

  

	18.1.5	acts in any manner which in the opinion of the Board brings or is likely to bring the Executive or the Group or any Group Company into disrepute or is materially adverse to the interests of the Group or any Group
Company; 

  

	18.1.6	is charged with or convicted of any offence in any jurisdiction (other than an offence under any road traffic legislation in the United Kingdom or elsewhere for which a fine or non-custodial penalty is imposed),
including any offence under any law or regulation relating to market abuse or insider dealing; 

  

	18.1.7	is declared bankrupt or makes any arrangement with or for the benefit of his creditors or has a county court administration order made against him under the County Courts Act 1984; 

 

	18.1.8	is disqualified from acting as a director or resigns as a director of Milacron or any Group Company without the prior written consent of the Board; or 

 

	18.1.9	ceases to be eligible to work in the United Kingdom (other than through the default of the Company). 

  

	18.2	The rights of the Company under clause 18.1 are without prejudice to any other rights that it might have at law to terminate the Executive’s employment or to accept any breach of this Agreement by the Executive as
having brought the Agreement to an end. Any delay by the Company in exercising its rights shall not constitute a waiver thereof. 

  

	19.	PAYMENTS ON TERMINATION 

  

	19.1	If the Executive’s employment is terminated by the Company in circumstances where Cause does not exist or by the Executive for Good Reason, the Company shall pay the Compensation Payment to the Executive in
addition to any contractual payments made during the notice period referred to in clause 2 or to any payment in lieu of notice made under clause 17. 

  
 11 

	19.2	Payment of the Compensation Payment is conditional upon and in consideration of the Executive having complied with clauses 21 and 23 and having complied with and continuing to comply with clauses 15, 16 and 22.

  

	19.3	The Compensation Payment shall be paid in six equal consecutive monthly instalments after Termination less such deductions as are required by law and will be accepted by the Executive in full and final settlement of all
claims or rights of action which the Executive may have against the Company or any Group Company and their respective officers and employees arising out of or in connection with his employment or Termination, any directorships or their termination
or otherwise, whether they are contractual or statutory or arise under English, U.S.A., or European law, except for any claim for personal injury arising out of any failure by the Group to comply with its legal obligations under relevant health and
safety legislation. 

  

	19.4	For the avoidance of doubt: 

  

	19.4.1	the Compensation Payment shall not be payable by the Company if it terminates the Executive’s employment where Cause exists or if the Executive terminates his employment where Good Reason does not exist or in
breach of this Agreement. 

  

	19.4.2	the sum of the Compensation Payment and any payment under clause 17 shall not exceed 18 months’ Base Salary. 

  

	20.	GARDEN LEAVE 

  

	20.1	Following service of notice to terminate the Executive’s employment by either party, or if the Executive purports to terminate his employment in breach of contract, the Company may by written notice place the
Executive on Garden Leave for the whole or part of the remainder of his employment. 

  

	20.2	During any period of Garden Leave: 

  

	20.2.1	the Board: 

  

	 	(a)	shall be under no obligation to provide any work to the Executive and any powers the Executive holds on behalf of the Company or any Group Company may be revoked; 

 

	 	(b)	may require the Executive to carry out alternative duties or to only perform such specific duties as are expressly assigned to the Executive, at such location (including the Executive’s home) as the Company may
decide; 

  

	 	(c)	may exclude the Executive from any premises of the Company or any Group Company; and 

  

	 	(d)	may require the Executive not to contact or deal with (or attempt to contact or deal with) any officer, employee, consultant, client, customer, supplier, agent, distributor, shareholder, adviser or other business
contact of the Company or any Group Company; 

  
 12 

	20.2.2	the Executive shall: 

  

	 	(a)	continue to receive his Base Salary and all contractual benefits subject to the terms of this Agreement; 

  

	 	(b)	shall remain an employee of the Company and will be bound by the terms of this Agreement and by the implied duties of his employment, including the duty of fidelity; 

 

	 	(c)	remain reasonably contactable during each working day; and 

  

	 	(d)	not without the prior written consent of the Board work for or provide services, whether for remuneration or not, to any person, firm or company other than the Company or any Group Company. 

 

	21.	OBLIGATIONS ON TERMINATION 

  

	21.1	On Termination or, if requested by the Board, during any period of Garden Leave the Executive shall: 

  

	21.1.1	resign immediately without compensation from any office or trusteeship that he holds in or on behalf of Milacron, the Company or any Group Company; 

 

	21.1.2	transfer without payment to the Company or as it may direct any shares or other securities held by him in the Company or any Group Company as a nominee or trustee for the Company or any Group Company and deliver to the
Company the related certificates; 

  

	21.1.3	immediately deliver to the Company all documents, books, materials, records, correspondence, papers and information (on whatever media and wherever located) relating to the business or affairs of the Group, any keys,
credit card and any other property of the Company or any Group Company, which is in his possession or under his control; 

  

	21.1.4	irretrievably delete any information relating to the business of the Group stored on any magnetic or optical disk or memory and all matter derived from such sources which is in his possession or under his control
outside the Company’s premises; and 

  

	21.1.5	provide if requested a signed statement that he has complied fully with his obligations under this clause 21.1. 

  

	21.2	The Executive hereby irrevocably appoints any member of the Board or any director of the Company from time to time to be his attorney to execute and do any such instrument or thing and generally to use his name for the
purpose of giving the Company or its nominee the full benefit of clause 21.1.1 and clause 21.1.2. 

  

	21.3	On Termination the Executive shall not be entitled under this Agreement to any compensation for the loss of any rights or benefits under any share option agreement, bonus, long-term incentive plan or other profit
sharing scheme operated by the Company or any Group Company in which he may participate and his rights thereunder shall be subject to the terms of such agreements, schemes or plans from time to time. 

  
 13 

	22.	POST-TERMINATION RESTRICTIONS 

  

	22.1	The Executive covenants with the Company (for itself and as trustee and agent for each Group Company) that he shall not directly or indirectly or on his own behalf or on behalf of, or in conjunction with, any firm,
company or person or other entity for 12 months immediately following Termination: 

  

	22.1.1	be involved in any Capacity in any Competing Business; 

  

	22.1.2	deal with any Restricted Customer in relation to Restricted Goods or Services; 

  

	22.1.3	deal with any Prospective Customer in relation to Restricted Goods or Services; 

  

	22.1.4	solicit or endeavour to entice away from the Company or any Group Company the business of any Restricted Customer on behalf of any Competing Business; 

 

	22.1.5	solicit or endeavour to entice away from the Company or any Group Company the business of any Prospective Customer on behalf of any Competing Business; 

 

	22.1.6	on behalf of any Competing Business, offer to employ or engage or otherwise endeavour to solicit or entice away from the Company or any Group Company any person employed or engaged at the date of Termination by the
Company or any Group Company in a senior management, sales, marketing or technical position; 

  

	22.1.7	solicit or approach any Restricted Supplier for the purpose of procuring that such Restricted Supplier cease to do business with the Company or any Group Company, reduce the amount of business conducted with the Company
or any Group Company or adversely vary the terms on which it does business with Company or any Group Company; 

  

	22.2	The period for which the restrictions in clauses 22.1.1-22.1.7 apply shall be reduced by up to six months of any period that the Executive spends on Garden Leave. 

 

	22.3	The Executive will not at any time after Termination represent himself as being connected with the Company or any Group Company in any Capacity. 

 

	22.4	None of the restrictions in clause 22.1 shall prevent the Executive from holding an investment by way of shares or other securities of not more than 3% of the total issued share capital of any company whose shares are
listed or dealt in on a recognised investment exchange. 

  

	22.5	If during his employment or before the expiry of the last of the restrictions in this clause 22, the Executive receives an offer to be involved in a business in any Capacity the Executive shall before accepting such an
offer or commencing such involvement give the person making the offer a copy of this clause 22 and shall immediately notify the Board of the identity of that person. 

 

	22.6	The Executive entered into the restrictions in this clause 22 having had the opportunity to be separately legally advised. 

  
 14 

	22.7	Each of the restrictions in this clause 22 is intended to be separate and severable. If any of the restrictions shall be held to be void but would be valid if part of their wording were deleted, such restriction shall
apply with such deletion as may be necessary to make it valid or effective. 

  

	22.8	The Executive will, at the request and expense of the Company, enter into a separate agreement with any Group Company in which he agrees to be bound by restrictions corresponding to those restrictions in this clause 22
(or such of those restrictions as the Company deems appropriate) in relation to that Group Company. 

  

	23.	RELEASE AND REAFFIRMATION 

 The Executive’s entitlement to the Compensation Payment
and to any bonus to which he may be entitled on Termination under clause 9.5 is conditional upon him having irrevocably entered into the Release prior to receiving any part of whichever of such payments, if any, first becomes due and to having
irrevocably signed the Reaffirmation Letter prior to receiving any part of whichever of such payments, if any, is the second to become due. 
  

	24.	DISCIPLINARY AND GRIEVANCE PROCEDURES 

  

	24.1	The Executive is subject to the Company’s disciplinary and grievance procedures, copies of which are available on request. Those procedures do not form part of the Executive’s contract of employment. The
Executive should address any grievance relating to his employment to the CEO. 

  

	24.2	The Board may suspend the Executive from any or all of his duties for a reasonable period in order to investigate any disciplinary matter involving the Executive or during any disciplinary procedure against the
Executive. During such suspension the terms of clauses 20.2.1 and 20.2.2 shall apply. 

  

	25.	DATA PROTECTION 

  

	25.1	The Executive consents to the Company or any Group Company processing data relating to the Executive for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive
personal data (as defined in the Data Protection Act 1998) relating to the Executive and to the Company making such information available to any Group Company, those who provide products or services to the Company or any Group Company (such as
advisers and payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company or the business in which the Executive works. 

 

	25.2	The Executive consents to the transfer of such information to any Group Company and the Company’s or any Group Company’s business contacts outside the European Economic Area in order to further their business
interests. 

  
 15 

	26.	RECONSTRUCTION AND AMALGAMATION 

  

	 	If the Executive’s employment is terminated at any time by reason of any reconstruction or amalgamation of the Group, the Company or any Group Company, whether by winding up or otherwise, and the Executive is
offered employment with any concern or undertaking involved in or resulting from the reconstruction or amalgamation on terms which (considered in their entirety) are no less favourable to any material extent than the terms of this Agreement, the
Executive shall have no claim against the Company, any Group Company or any such undertaking arising out of or connected with such Termination. 

  

	27.	NOTICES 

  

	27.1	A notice given to a party under this Agreement shall be in writing in the English language and signed by or on behalf of the party giving it. A notice to the Executive shall be delivered by hand or sent to the Executive
at the address given in this Agreement or as otherwise notified in writing by the Executive to the Company. A notice to the Company shall be sent to the Company Secretary with a simultaneous copy to: 

Chief Executive Officer 

Milacron LLC 
 3010 Disney
Street 
 Cincinnati, OH 45209 

USA 
  

	27.2	Any such notice shall be deemed to have been received: 

  

	27.2.1	if delivered by hand, at the time the notice is left at the address or given to the addressee; or 

  

	27.2.2	in the case of pre-paid first class UK post or other next working day delivery service, at 9.00am on the second business day after posting or at the time recorded by the delivery service; or 

 

	27.2.3	in the case of pre-paid airmail, 9.00am on the fifth Business Day after posting or at the time recorded by the delivery service. 

  

	27.3	A notice shall have effect from the earlier of its actual or deemed receipt by the addressee and for the purpose of calculating deemed receipt: 

 

	27.3.1	all references to time are to local time in the place of deemed receipt; and 

  

	27.3.2	if deemed receipt would occur on a Saturday or Sunday or a public holiday when clearing banks are not open for business, deemed receipt is at 9.00am on the next business day. 

 

	27.4	A notice required to be given under this Agreement shall not be validly given if sent by e-mail. 

  

	27.5	This clause does not apply to the service of any proceedings or other documents in any legal action. 

  
 16 

	28.	ENTIRE AGREEMENT AND VARIATION 

  

	28.1	This Agreement constitutes the whole agreement between the parties in relation to its subject matter and supersedes all previous discussions, correspondence, negotiations, arrangements, understandings and agreements
between them or between the Executive and the Company or any Group Company. 

  

	28.2	Each party acknowledges that in entering into this Agreement it has not relied on and shall have no remedy in respect of any undertaking, promise, assurance, statement, representation, warranty or understanding (whether
in writing or not) of any person (whether party to this Agreement or not) relating to the Executive’s employment under this Agreement which is not expressly set out in this Agreement. 

 

	28.3	Each party agrees that its only liability in respect of those representations and warranties that are set out in this Agreement (whether made innocently or negligently) shall be for breach of contract.

  

	28.4	Nothing in this Agreement shall limit or exclude any liability for fraud. 

  

	28.5	No variation or agreed termination of this Agreement shall be effective unless it is in writing and signed by the parties (or their authorised representatives). 

 

	28.6	There is no collective agreement which directly affects the Executive’s employment. 

  

	29.	COUNTERPARTS 

  

	 	This Agreement may be executed in any number of counterparts, each of which, when executed, shall be an original, and all the counterparts together shall constitute one and the same instrument. 

 

	30.	THIRD PARTY RIGHTS 

  

	 	Any Group Company may enforce the Company’s rights under this Agreement but no other person other than a party to this Agreement may enforce any of its terms. 

 

	31.	GOVERNING LAW AND JURISDICTION 

  

	31.1	This Agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with
English law. 

  

	31.2	The parties irrevocably agree that the courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim that arises out of or in connection with this Agreement or its subject matter or
formation (including non-contractual disputes or claims). 

 This Agreement has been executed as a deed and is delivered and takes effect on
the date stated at the beginning of it. 

  
 17 

							
	 Signed as a deed by
 MILACRON UK LIMITED
acting by a
 director
				Name:		G. van Deventer
				
					Signature:		 /s/ G. van Deventer

							

  

	
	in the presence of:
	
	 /s/ N Kwok

	 Signature of witness
 Name, address and
occupation of
 witness:

	N Kwok
	Schiedamsedijk 20
	3134 K.K. Vlaardingen
	Secretary

  

							
	 Signed as a deed by
 RONALD M.
KRISANDA
						/s/ Ronald M. Krisanda
							Signature

  

	
	in the presence of:
	
	 /s/ Linda Eha

	 Signature of witness
 Name, address and
occupation of
 witness:

	Linda Eha
	3010 Disney St.
	Cincinnati, OH 45209
	Executive Assistant

  
 18 

 SCHEDULE 1 

Annual Bonus Scheme 
 The preliminary 2013
bonus scheme, which is being developed by the Board, consists of financial goals and non-financial goals, with threshold, target and stretch levels of performance to be set against each goal (target paying out 60% of Base Salary). The preliminary
bonus scheme is subject to change and final approval by the Board, and the bonus scheme may be modified from year to year as determined by the Board. 

  
 19 

 SCHEDULE 2 

Form of Release and Reaffirmation Letter 

[rest of page left intentionally blank] 

  
 20 

 GENERAL RELEASE OF CLAIMS 

This General Release of all Claims (this “Agreement”) is entered into by Ron Krisanda (the “Executive”) and Mcron
Acquisition Corp. (the “Company”), effective as of                     , in connection with the termination of the
Executive’s employment with the Milacron UK Limited (“Milacron UK”) and his employment agreement with Milacron UK (the “Employment Agreement”) as of
                    . 
 In consideration of the
promises set forth in the Employment Agreement the Executive and the Company agree as follows: 
 1. Return of Property. All Company
files, access keys and codes, desk keys, ID badges, computers, records, manuals, electronic devices, computer programs, papers, electronically stored information or documents, telephones and credit cards, and any other property of the Group in the
Executive’s possession must be returned no later than the date of the Executive’s termination from the Company; provided, that, after the notification of an consultation with the Company, the Executive may keep one copy of such
items as he may reasonably expect to use to protect his rights under this Agreement. 
 2. General Release and Waiver of Claims. 

(a) Release. In consideration of the payments and benefits provided to the Executive under the Employment Agreement and after
consultation with counsel, the Executive and each of the Executive’s respective heirs, executors, administrators, representatives, agents, insurers, successors and assigns (collectively, the “Releasors”) hereby irrevocably and
unconditionally release and forever discharge the Company, its subsidiaries and affiliates and each of their respective officers, employees, directors, shareholders and agents (“Releasees”) from any and all claims, actions, causes
of action, rights, judgments, obligations, damages, demands, accountings or liabilities of whatever kind or character (collectively, “Claims”), including, without limitation, any Claims under any federal, state, local or foreign
law, that the Releasors may have, or in the future may possess, arising out of (i) the Executive’s employment relationship with and service as an employee, officer or director of the Company or any subsidiaries or affiliated companies and
the termination of such relationship or service, and (ii) any event, condition, circumstance or obligation that occurred, existed or arose on or prior to the date hereof; provided, however, that the Executive does not release, discharge or
waive any rights to (i) payments and benefits provided under the Employment Agreement that are contingent upon the execution by the Executive of this Agreement and (ii) any indemnification rights the Executive may have under the Employment
Agreement, in accordance with the Company’s governance instruments or under any director and officer liability insurance maintained by the Company or any subsidiary or affiliate with respect to liabilities arising as a result of the
Executive’s service as an officer and employee of the Company. This Section 2(a) does not apply to any Claims that the Releasors may have as of the date the Executive signs this Agreement arising under the Federal Age Discrimination
in Employment Act of 1967, as amended, and the applicable rules and regulations promulgated thereunder (“ADEA”). Claims arising under ADEA are addressed in Section 2(b) of this Agreement. 

  
 21 

 (b) Specific Release of ADEA Claims. In further consideration of the payments and benefits
provided to the Executive under the Employment Agreement, the Releasors hereby unconditionally release and forever discharge the Releasees from any and all Claims arising under ADEA that the Releasors may have as of the date the Executive signs this
Agreement. By signing this Agreement, the Executive hereby acknowledges and confirms the following: (i) the Executive was advised by the Company in connection with his termination to consult with an attorney of his choice prior to signing this
Agreement and to have such attorney explain to the Executive the terms of this Agreement, including, without limitation, the terms relating to the Executive’s release of claims arising under ADEA, and the Executive has in fact consulted with an
attorney; (ii) the Executive was given a period of not fewer than 21 days to consider the terms of this Agreement and to consult with an attorney of his choosing with respect thereto; (iii) the Executive knowingly and voluntarily accepts
the terms of this Agreement; and (iv) the Executive is providing this release and discharge only in exchange for consideration in addition to anything of value to which the Executive is already entitled. The Executive also understands that he
has seven days following the date on which he signs this Agreement within which to revoke the release contained in this paragraph, by providing the Company with a written notice of his revocation of the release and waiver contained in this
paragraph. 
 (c) No Assignment. The Executive represents and warrants that he has not assigned any of the Claims being released
under this Agreement. The Company may assign this Agreement, in whole or in part, to any affiliated company or subsidiary of, or any successor in interest to, the Company. 

3. Proceedings. 
 (a)
General Agreement Relating to Proceedings. The Executive has not filed, and except as provided in Sections 3(b) and 3(c), the Executive agrees not to initiate or cause to be initiated on his behalf, any complaint, charge, claim
or proceeding against the Releasees before any local, state or federal agency, court or other body relating to his employment or the termination of his employment, other than with respect to the obligations of the Company to the Executive under the
Employment Agreement (each, individually, a “Proceeding”), and agrees not to participate voluntarily in any Proceeding. The Executive waives any right he may have to benefit in any manner from any relief (whether monetary or
otherwise) arising out of any Proceeding. 
 (b) Proceedings Under ADEA. Section 3(a) shall not preclude the Executive
from filing any complaint, charge, claim or proceeding challenging the validity of the Executive’s waiver of Claims arising under ADEA (which is set forth in Section 2(b) of this Agreement). However, both the Executive and the Company
confirm their belief that the Executive’s waiver of claims under ADEA is valid and enforceable, and that their intention is that all claims under ADEA will be waived. 

(c) Certain Administrative Proceedings. In addition, Section 3(a) shall not preclude the Executive from filing a charge
with or participating in any administrative investigation or proceeding by the Equal Employment Opportunity Commission or another Fair Employment Practices agency. The Executive is, however, waiving his right to recover money in connection with any
such charge or investigation. The Executive is also waiving his right to recover money in connection with a charge filed by any other entity or individual, or by any federal, state or local agency. 

  
 22 

 4. Remedies. In the event the Executive initiates or voluntarily participates in any
Proceeding in violation of this Agreement, or if he fails to abide by any of the terms of this Agreement or his post-termination obligations contained in the Employment Agreement, or if he revokes the ADEA release contained in paragraph 2(b) within
the seven-day period provided under paragraph 2(b), the Company may, in addition to any other remedies it may have, reclaim any amounts paid to him under the termination provisions of the Employment Agreement or terminate any benefits or payments
that are subsequently due under the Employment Agreement, without waiving the release granted herein. The Executive acknowledges and agrees that the remedy at law available to the Company for breach of any of his post-termination obligations under
the Employment Agreement or his obligations under paragraphs 2 and 3 herein would be inadequate and that damages flowing from such a breach may not readily be susceptible to measurement in monetary terms. Accordingly, the Executive acknowledges,
consents and agrees that, in addition to any other rights or remedies that the Company or any subsidiary or affiliate may have at law or in equity or as may otherwise be set forth in the Employment Agreement, the Company shall be entitled to seek a
temporary restraining order or a preliminary or permanent injunction, or both, without bond or other security, restraining the Executive from breaching his post-termination obligations under the Employment Agreement or his obligations under
paragraphs 2 and 3 herein. Such injunctive relief in any court shall be available to the Company or any subsidiary or affiliate, in lieu of, or prior to or pending determination in, any arbitration proceeding. 

The Executive understands that by entering into this Agreement he shall be limiting the availability of certain remedies that he may have against the Company
and limiting also his ability to pursue certain claims against the Company. 
 5. Severability Clause. In the event that any
provision or part of this Agreement is found to be invalid or unenforceable, only that particular provision or part so found, and not the entire Agreement, shall be inoperative. 

6. Nonadmission. Nothing contained in this Agreement shall be deemed or construed as an admission of wrongdoing or liability on the
part of the Company or the Executive. 
 7. Governing Law and Forum. Except only as provided in the Exhibit, the Executive and the
Company agree that this Agreement and all matters or issues arising out of or relating to it shall be governed by the laws of the State of Delaware and that any action to enforce this Agreement shall be brought solely in the state or federal courts
located in the City of Cincinnati, Ohio. 

  
 23 

 8. Notices. All notices or communications hereunder shall be in writing, addressed as
follows: 
 To the Company: 

Mcron Acquisition Corp. 
 3010
Disney Street 
 Cincinnati, OH 45209 

Attn.: Tom Goeke 
 Email:
tom_goeke@milacron.com 
 Facsimile: (513) 487-5086 

To the Executive: 
 Ron Krisanda

 _________________ 

_________________ 
 Email:
_________________ 
 Facsimile: _________________ 

All such notices shall be conclusively deemed to be received and shall be effective (i) if sent by hand delivery or nationally recognized
courier, upon receipt or (ii) if sent by electronic mail or facsimile, upon receipt by the sender of such transmission. 
 THE
EXECUTIVE ACKNOWLEDGES THAT HE HAS READ THIS AGREEMENT AND THAT HE FULLY KNOWS, UNDERSTANDS AND APPRECIATES ITS CONTENTS, AND THAT HE HEREBY EXECUTES THE SAME AND MAKES THIS AGREEMENT AND THE RELEASE AND AGREEMENTS PROVIDED FOR HEREIN VOLUNTARILY
AND OF HIS OWN FREE WILL. 

  
 24 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first set forth
above. 
  

					
	MCRON ACQUISITION CORP.
		
	By:	 	 
		 	Name:	 	
		 	Title:	 	

  
  

			
	THE EXECUTIVE
	
	 
	Ron Krisanda
		
	Dated:	 	 

  
  

  
 25 

 EXHIBIT TO GENERAL RELEASE OF CLAIMS 

CLAIMS IN THE UNITED KINGDOM 
  

	1.	Waiver of claims 

  

	(a)	The Executive agrees that the terms of this Agreement are offered by the Company without any admission of liability on the part of any of the Releasees and are in full and final settlement of: 

 

	(i)	the Executive’s particular claims for: 

  

	 	(A)	unfair dismissal and related claims under sections 93 and 111 of the Employment Rights Act 1996; 

  

	 	(B)	breach of contract or wrongful dismissal, including any compensation for the loss of any rights or benefits under any share option, bonus, long-term incentive plan or other profit sharing scheme operated by any
subsidiary or affiliate which he may participate; 

  

	 	(C)	in relation to an unauthorised deduction from wages or unauthorised payment under section 23 of the Employment Rights Act 1996; 

  

	 	(D)	a statutory redundancy payment, under section 163 of the Employment Rights Act 1996; 

  

	(ii)	all and any other claims or rights of action that the Executive has or may have under English law against any of the Releasees whether arising out of his employment with Milacron UK or its termination or from events
occurring after the date hereof, whether under common law, contract, statute or otherwise including his holding any office or resigning any office in the Company or any subsidiary or affiliate and whether such claims are, or could be, known to the
parties or in their contemplation at the date hereof in any jurisdiction (each of which is hereby intimated and waived). 

  

	(b)	This Exhibit will not apply to any claim for personal injury and/or industrial disease that may be brought under English law save for those which the Executive is aware or ought reasonably be aware of at the date hereof
or any claim in relation to accrued entitlements under any pension scheme of which the Executive is a member. 

  

	(c)	The Executive warrants and represents to the Company that: 

  

	(i)	before entering into this Agreement he received independent advice from the Adviser named below as to the effect of this Exhibit on his ability to pursue any complaint before an employment tribunal in the United
Kingdom; 

  

	(ii)	before receiving the advice he disclosed to the Adviser all facts or circumstances that may give rise to a claim against any of the Releasees and confirmed that he is not aware of any other facts or circumstances that
may give rise to any claim against the Releasees other than those claims specified in clause 1(a)(i)(a) and (ii) of this Exhibit; 

  
 26 

	(iii)	he is not aware of any circumstances which may give rise to a claim for personal injury and/or industrial disease. 

  

	(d)	Notwithstanding the terms of this Agreement, the Executive acknowledges that the restrictions in clauses 15, 16 and 22 of the Employment Agreement will continue to apply. 

 

	2.	Compromise Agreement 

  

	(a)	The parties intend that the conditions relating to compromise agreements under the following UK legislation have been satisfied by this Agreement: section 147 of the Equality Act 2010, section 77(4A) of the Sex
Discrimination Act 1975 (in relation to claims under that Act and the Equal Pay Act 1970), section 72(4A) of the Race Relations Act 1976, paragraph 2 of Schedule 3A to the Disability Discrimination Act 1995, paragraph 2(2) of Schedule 4 to the
Employment Equality (Sexual Orientation) Regulations 2003, paragraph 2(2) of Schedule 4 to the Employment Equality (Religion or Belief) Regulations 2003, paragraph 2(2) of Schedule 5 to the Employment Equality (Age) Regulations 2006, section 288(2B)
of the Trade Union and Labour Relations (Consolidation) Act 1992, section 203(3) of the Employment Rights Act 1996, regulation 35(3) of the Working Time Regulations 1998, section 49(4) of the National Minimum Wage Act 1998, regulation 41(4) of the
Transnational Information and Consultation etc. Regulations 1999, regulation 9 of the Part-Time Workers (Prevention of Less Favourable Treatment) Regulations 2000, regulation 10 of the Fixed-Term Executives (Prevention of Less Favourable Treatment)
Regulations 2002, regulation 40(4) of the Information and Consultation of Executives Regulations 2004 and paragraph 12 of the Schedule to the Occupational and Personal Pension Schemes (Consultation by Employers and Miscellaneous Amendment)
Regulations 2006. 

  

	(b)	This Exhibit will be governed by and construed in accordance with the law of England and Wales and each party irrevocably agrees to submit to the non-exclusive jurisdiction of the courts of England and Wales over any
claim or matter arising under or in connection with this Exhibit. 

  

	(c)	This Exhibit will be deemed to be without prejudice and subject to contract until such time as it is signed and dated by both parties, when it will be treated as an open document evidencing a binding agreement.

  

	3.	Adviser’s first certificate 

  

	(a)	By signing this Exhibit the Adviser named below confirms that: 

  

	(i)	he/she is a solicitor holding a current practising certificate 

  
 27 

	(ii)	he/she has given the Executive legal advice on the terms and effect of this Exhibit and, in particular, its effect on his ability to pursue the claims before an employment tribunal in the United Kingdom;

  

	(iii)	he/she gave the advice to the Executive as a relevant independent adviser within the meaning of the legislation referred to in clause 2(a) of this Exhibit; 

 

	(iv)	there is now in force (and was in force at the time he/she gave the advice referred to above) a policy of insurance or an indemnity provided for members of a profession or professional body covering the risk of claim by
the Executive in respect of loss arising in consequence of the advice he/she has given him. 

  

			
	Signed by the Adviser: __________________________________________________________		
		
	Name: _______________________________________________________________________		
		
	Firm: ________________________________________________________________________		
		
	Address: _____________________________________________________________________		
		
	____________________________________________________________________________		
		
	_____________________________________________________________________________		
		
	Dated: _______________________________________________________________________		

  
 28 

 REAFFIRMATION LETTER 

[DATE] 
 Dear Sirs 

In respect of the General Release dated [DATE] made between me and Mcron Acquisition Corp. (“Company”) including the Exhibit thereto
(“Release”), I confirm the following as at today’s date: 
 WARRANTY AND REPRESENTATION 

 

	1.	I warrant and represent to the Company that: 

  

	1.1.	I received independent advice from the Adviser (as defined in the Release) as to the terms and effect of this letter and, in particular, its effect on my ability to pursue any complaint before a United Kingdom
employment tribunal; 

  

	1.2.	the Adviser confirmed to me that they are a solicitor holding a current practising certificate and that there is in force a policy of insurance covering the risk of a claim by me in respect of any loss arising in
consequence of their advice; 

  

	1.3.	the Adviser shall sign and deliver to the Company a certificate in the form attached below; 

  

	1.4.	before receiving the advice referred to above I disclosed to the Adviser all facts or circumstances that may give rise to a claim against any Releasee (as defined in the Release) or their officers or employees and that
I am not aware of any other facts or circumstances that may give rise to any claim under English law against any Releasee other than those claims specified in (and waived in) the Release; 

 

	1.5.	except as set out in the Exhibit to the Release the only claims that I have or may have against any Releasee (whether at the time of signing this letter or in the future) relating to my employment with Milacron UK
Limited or its termination are those specified in (and waived in) the Release; 

  

	1.6.	I am not aware of any circumstances which may give rise to a claim for personal injury and/or industrial disease against any Releasee; and 

 

	1.7.	I agree that, except for the payments and benefits provided for in the Release and subject to the waiver in the Release, I shall not be eligible for any further payment from the Company or any subsidiary or affiliate
relating to my employment or holding of office or their termination and without limitation to the generality of the foregoing, I expressly waive any right or claim that I have or may have to payment of bonuses, any benefit or award programme, or to
any other benefit, payment or award that I may have received had my employment or office not terminated. 

  
 29 

	2.	I hereby re-affirm my acceptance of the terms of the Release and, in particular, the waiver of claims set out in the Release. 

  

	
	Yours faithfully
	
	  

	Ronald M. Krisanda

 ADVISER’S SECOND CERTIFICATE 

By signing this Reaffirmation Letter the Adviser named below confirms that: 
  

	1.	he/she is a solicitor holding a current practising certificate; 

  

	2.	he/she has given the Executive legal advice on the terms and effect of this Reaffirmation Letter and, in particular, its effect on his ability to pursue the claims before an employment tribunal in the United Kingdom;

  

	3.	he/she gave the advice to the Executive as a relevant independent adviser within the meaning of the United Kingdom legislation referred to in clause 2(a) of the Exhibit to the Release; 

 

	4.	there is now in force (and was in force at the time he/she gave the advice referred to above) a policy of insurance or an indemnity provided for members of a profession or professional body covering the risk of claim by
the Executive in respect of loss arising in consequence of the advice he/she has given him. 

  

			
	Signed by the Adviser: __________________________________________________________		
		
	Name: _______________________________________________________________________		
		
	Firm: ________________________________________________________________________		
		
	Address: _____________________________________________________________________		
		
	____________________________________________________________________________		
		
	_____________________________________________________________________________		
		
	Dated: _______________________________________________________________________		

  
 30

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]